{
  "schema_version": "0.1.0",
  "case_id": "HR-ML036",
  "record_classification": {
    "synthetic": true,
    "banner": "SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD",
    "real_historical_name": true,
    "public_release_status": "draft"
  },
  "identity": {
    "person_id": "ML036",
    "display_name": "Wilma Rudolph",
    "aliases": [
      "Wilma Glodean Rudolph"
    ],
    "sex": "female",
    "era": "Mid-Late 20th Century",
    "nationality": "American",
    "historical_dates": {
      "birth": {
        "preferred": {
          "iso": "1940-06-23",
          "display": "June 23, 1940",
          "precision": "day",
          "calendar": "gregorian"
        },
        "alternatives": [
          {
            "date": {
              "iso": "1940",
              "display": "1940",
              "precision": "year",
              "calendar": "gregorian"
            },
            "source_ids": [
              "SRC-0007"
            ],
            "resolution_status": "preferred",
            "note": "Roster year agrees with Olympedia, the U.S. Olympic & Paralympic Museum and the Tennessee Encyclopedia. Birthplace is given as Saint Bethlehem (Olympedia, the museum) or Clarksville (Tennessee Encyclopedia, the Deseret News); Saint Bethlehem is a community near Clarksville."
          }
        ]
      },
      "death": {
        "preferred": {
          "iso": "1994-11-12",
          "display": "November 12, 1994",
          "precision": "day",
          "calendar": "gregorian"
        },
        "alternatives": [
          {
            "date": {
              "iso": "1994",
              "display": "1994",
              "precision": "year",
              "calendar": "gregorian"
            },
            "source_ids": [
              "SRC-0007"
            ],
            "resolution_status": "preferred",
            "note": "Roster year agrees with the obituary and reference sources."
          }
        ]
      }
    },
    "synthetic_identity": {
      "mrn": "HR-ML036-SYN",
      "ssn": "000-36-5170",
      "date_of_birth": "1972-06-23",
      "name_policy": "real_historical_name",
      "fictional_facility": "St. Posthumous Health Center",
      "fictional_primary_clinician": "Gloria Haynes-Whitaker, MD",
      "fictional_consultant": {
        "name": "Tomasz Brzezinski, MD",
        "specialty": "Neuro-Oncology"
      }
    }
  },
  "historical_timeline": [
    {
      "event_id": "EVT-0001",
      "date": {
        "iso": "1940-06-23",
        "display": "June 23, 1940",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Born prematurely in Saint Bethlehem, near Clarksville, Tennessee, weighing about 4.5 pounds.",
      "claim_ids": [
        "CLM-0001",
        "CLM-0002"
      ]
    },
    {
      "event_id": "EVT-0002",
      "date": {
        "iso": "1944",
        "display": "about 1944",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Double pneumonia and scarlet fever at about four; polio in early childhood leaves the left leg partly paralyzed.",
      "claim_ids": [
        "CLM-0003",
        "CLM-0004"
      ]
    },
    {
      "event_id": "EVT-0003",
      "date": {
        "iso": "1946",
        "display": "about 1946",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Wears a metal leg brace and special shoe; weekly treatment at Meharry Medical College in Nashville, with massage at home.",
      "claim_ids": [
        "CLM-0005"
      ]
    },
    {
      "event_id": "EVT-0004",
      "date": {
        "iso": "1952",
        "display": "about 1952",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Walks without the brace by about twelve, after taking it off in public at about nine and a half.",
      "claim_ids": [
        "CLM-0006"
      ]
    },
    {
      "event_id": "EVT-0005",
      "date": {
        "iso": "1956",
        "display": "1956",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Wins a bronze medal in the 4 x 100-meter relay at the Melbourne Olympics, at sixteen.",
      "claim_ids": [
        "CLM-0007"
      ]
    },
    {
      "event_id": "EVT-0006",
      "date": {
        "iso": "1960",
        "display": "1960",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Wins three gold medals at the Rome Olympics: 100 meters, 200 meters and the 4 x 100-meter relay.",
      "claim_ids": [
        "CLM-0007"
      ]
    },
    {
      "event_id": "EVT-0007",
      "date": {
        "iso": "1992",
        "display": "1992",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Returns to Tennessee as a vice president of a Nashville hospital.",
      "claim_ids": [
        "CLM-0008"
      ]
    },
    {
      "event_id": "EVT-0008",
      "date": {
        "iso": "1994-11-12",
        "display": "November 12, 1994",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Dies of brain cancer at her home in Brentwood, Tennessee, at 54, after a diagnosis earlier that year, reported shortly after her mother's death.",
      "claim_ids": [
        "CLM-0009",
        "CLM-0010"
      ]
    }
  ],
  "claims": [
    {
      "claim_id": "CLM-0001",
      "statement": "Wilma Glodean Rudolph was born on June 23, 1940, in Saint Bethlehem, Tennessee, near Clarksville, the twentieth of twenty-two children in her father's family. She grew up in a large, poor Black family in the segregated South.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "source_links": [
        {
          "source_id": "SRC-0005",
          "relationship": "supports",
          "locator": "Born 23 June 1940 in Saint Bethlehem, Tennessee"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "born June 23, 1940, in Saint Bethlehem, Tennessee"
        },
        {
          "source_id": "SRC-0003",
          "relationship": "supports",
          "locator": "the twentieth of twenty-two children, was born June 23, 1940, in Clarksville"
        },
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "born on June 23, 1940 in Saint Bethlehem, Tennessee; one of 22 children"
        },
        {
          "source_id": "SRC-0006",
          "relationship": "supports",
          "locator": "born June 23, 1940, in Clarksville, Tenn., the 20th of 22 children"
        },
        {
          "source_id": "SRC-0007",
          "relationship": "context",
          "locator": "roster birth year 1940"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0002",
      "statement": "She was born prematurely and weighed about 4.5 pounds at birth.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Low birth weight is part of her early medical history; it carries no specific risk for the modern episode.",
      "source_links": [
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "born prematurely and weighed just 4 1/2 pounds"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "born prematurely in 1940; their 4.5-pound newborn"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0003",
      "statement": "She was often ill as a small child: at about age four she had double pneumonia followed by scarlet fever, and she had a number of other childhood illnesses before polio.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "source_links": [
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "at age 4, suffered from several ailments, including double pneumonia and scarlet fever"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "a bout of double pneumonia at age four which was followed immediately by scarlet fever"
        },
        {
          "source_id": "SRC-0003",
          "relationship": "supports",
          "locator": "a number of childhood diseases before contracting polio"
        },
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "survived bouts of polio and scarlet fever"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0004",
      "statement": "In early childhood she had polio, which left her left leg paralyzed or partly paralyzed, with the foot turned inward. Sources give her age at the illness as an infant, about four, or about five.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "The documented polio is recorded as late effects of poliomyelitis in the past medical history and on the problem list, and the modern episode treats the once-weak left leg as a factor in mobility and falls.",
      "source_links": [
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "She contracted polio. Her left leg was paralyzed"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "a mild form of polio resulted in a crooked and partially paralyzed left leg, with the foot turned inward"
        },
        {
          "source_id": "SRC-0005",
          "relationship": "supports",
          "locator": "contracted polio as an infant"
        },
        {
          "source_id": "SRC-0003",
          "relationship": "supports",
          "locator": "contracting polio"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0005",
      "statement": "She wore a metal leg brace for several years (from about age six to ten in one account) and a specially made shoe. Once a week her mother took her by bus to Nashville, a 90-minute round trip, to the closest doctors who would treat her in the segregated South: physicians at Meharry Medical College, a historically Black medical school, fitted the brace and prescribed massage and heat. At home her family massaged the leg several times a day.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Anchors the modern equity teaching: as a child she had to travel to a Black medical school for care that was not offered to her nearer home.",
      "source_links": [
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "metal brace that she wore for several years; specially-made shoe; weekly to Nashville via bus, a 90-minute roundtrip, to the closest doctor they could find to treat Rudolph in the segregated south"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "Two African-American doctors at Meharry Medical College in Nashville fitted her leg with a corrective metal brace, then prescribed regular massage and heat treatments; once a week for several years"
        },
        {
          "source_id": "SRC-0003",
          "relationship": "supports",
          "locator": "she wore leg braces from age six until she was ten years old"
        },
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "parents and siblings took turns; remove her leg brace and massage her injured leg"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0006",
      "statement": "She later wrote that a doctor told her she would never walk again, and that her mother told her she would. Accounts of her recovery differ: she took the brace off in public at about nine and a half, could move about with the brace by eight, was running by eleven, and no longer needed the brace by about twelve.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "my doctor told me I would never walk again. My mother told me I would. I believed my mother; by eight she could move around with a leg brace"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "Rudolph's autobiography; by age 11, somehow, Rudolph was able to run"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "At age 9 1/2, she took the brace off in public, and by the time she was 12 the device went back to Nashville"
        },
        {
          "source_id": "SRC-0006",
          "relationship": "supports",
          "locator": "leg braces as a child that kept her from walking until age 9"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0007",
      "statement": "At sixteen she won a bronze medal in the 4 x 100-meter relay at the 1956 Olympic Games in Melbourne. At the 1960 Games in Rome she won gold in the 100 meters, the 200 meters and the 4 x 100-meter relay, the first American woman to win three gold medals in track and field at one Olympics. She ran for the Tennessee State University Tigerbelles.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Her athletic career anchors the modern social history and the strength of the once-weak left leg.",
      "source_links": [
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "bronze medal from the 4x100-meter relay team; gold in the 100- and 200-meter dash races, as well as the 4x100-meter relay"
        },
        {
          "source_id": "SRC-0005",
          "relationship": "supports",
          "locator": "1956 bronze 4 x 100 m relay; 1960 gold 100 m, 200 m and 4 x 100 m relay"
        },
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "first American woman to win three gold medals in track and field at the same Olympic game"
        },
        {
          "source_id": "SRC-0006",
          "relationship": "supports",
          "locator": "first American woman to win three gold medals in track and field at one Olympics"
        },
        {
          "source_id": "SRC-0003",
          "relationship": "supports",
          "locator": "Tigerbelles; three gold medals at Rome"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0008",
      "statement": "After retiring from competition she worked in teaching, coaching and community work, founded an organization to help amateur track and field athletes, and in 1992 returned to Tennessee as a vice president of a Nashville hospital.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Anchors the modern social history.",
      "source_links": [
        {
          "source_id": "SRC-0003",
          "relationship": "supports",
          "locator": "In 1992 ... returned to Tennessee to become a vice-president for Nashville's Baptist Hospital"
        },
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "founded an organization to help amateur track and field stars"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0009",
      "statement": "In 1994, shortly after her mother's death, she was diagnosed with brain cancer; two accounts add throat cancer. Afterwards she seldom appeared in public, and she was in and out of hospitals for more than five months as the cancer spread.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "The anchor for the modern episode. The type, location and treatment of her brain cancer were not made public; the throat cancer is reported without detail and is not used.",
      "source_links": [
        {
          "source_id": "SRC-0003",
          "relationship": "supports",
          "locator": "shortly after her mother's death, Rudolph was diagnosed with brain and throat cancer; thereafter she seldom appeared in public"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "Rudolph had brain cancer and throat cancer"
        },
        {
          "source_id": "SRC-0006",
          "relationship": "supports",
          "locator": "in and out of hospitals for more than five months as the cancer spread"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0010",
      "statement": "She died of brain cancer at her home in Brentwood, Tennessee, on November 12, 1994, at 54.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "The documented disease to which the synthetic diagnosis is linked. History only, stated without detail.",
      "source_links": [
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "On November 12, 1994, Wilma Rudolph died of brain cancer at her home in Brentwood, Tennessee"
        },
        {
          "source_id": "SRC-0005",
          "relationship": "supports",
          "locator": "12 November 1994 in Brentwood, Tennessee; a brain tumor"
        },
        {
          "source_id": "SRC-0006",
          "relationship": "supports",
          "locator": "died Saturday of brain cancer; died at her home"
        },
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "died of a brain tumor on November 12, 1994"
        },
        {
          "source_id": "SRC-0003",
          "relationship": "supports",
          "locator": "died on November 12, 1994"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    }
  ],
  "sources": [
    {
      "source_id": "SRC-0001",
      "title": "Norwood A. Wilma Rudolph",
      "publisher": "National Women's History Museum",
      "url": "https://www.womenshistory.org/education-resources/biographies/wilma-rudolph",
      "source_type": "other",
      "published": "2017",
      "accessed": "2026-11-04",
      "rights_note": "Museum biography; facts and her quoted words used with citation."
    },
    {
      "source_id": "SRC-0002",
      "title": "Wilma Rudolph: Olympic Sprinter (U.S. Olympic & Paralympic Hall of Fame)",
      "publisher": "U.S. Olympic & Paralympic Museum",
      "url": "https://usopm.org/Wilma-Rudolph",
      "source_type": "other",
      "published": "2026",
      "accessed": "2026-11-04",
      "rights_note": "Official Olympic hall of fame profile; facts used with citation."
    },
    {
      "source_id": "SRC-0003",
      "title": "Lovett BL. Wilma Rudolph (1940-1994) and the TSU Tigerbelles (Tennessee Encyclopedia)",
      "publisher": "Tennessee Historical Society",
      "url": "https://tennesseeencyclopedia.net/entries/wilma-rudolph-1940-1994-and-the-tsu-tigerbelles/",
      "source_type": "other",
      "published": "2017",
      "accessed": "2026-11-04",
      "rights_note": "State historical encyclopedia entry; facts used with citation."
    },
    {
      "source_id": "SRC-0004",
      "title": "Rudolph, Wilma (1940-1994). Women in World History: A Biographical Encyclopedia",
      "publisher": "Gale, via Encyclopedia.com",
      "url": "https://www.encyclopedia.com/women/encyclopedias-almanacs-transcripts-and-maps/rudolph-wilma-1940-1994",
      "source_type": "other",
      "published": "2002",
      "accessed": "2026-11-04",
      "rights_note": "Reference encyclopedia entry; facts used with citation."
    },
    {
      "source_id": "SRC-0005",
      "title": "Wilma Rudolph (Olympedia athlete profile)",
      "publisher": "Olympedia (OlyMADMen)",
      "url": "https://www.olympedia.org/athletes/77958",
      "source_type": "other",
      "published": "2026",
      "accessed": "2026-11-04",
      "rights_note": "Olympic statistics database; dates, places and results used with citation."
    },
    {
      "source_id": "SRC-0006",
      "title": "Former Olympic sprinter Wilma Rudolph dies at 54",
      "publisher": "Deseret News",
      "url": "https://www.deseret.com/1994/11/13/19142355/former-olympic-sprinter-wilma-rudolph-dies-at-54",
      "source_type": "other",
      "published": "1994-11-13",
      "accessed": "2026-11-04",
      "rights_note": "Newspaper obituary published the day after her death; facts and a short quotation used with citation."
    },
    {
      "source_id": "SRC-0007",
      "title": "HISTMED Master Roster v3",
      "publisher": "The Human Record project",
      "url": "https://humanrecord.example.org/internal/HISTMED_Master_Roster_v3.xlsx",
      "source_type": "other",
      "published": "2026-11-04",
      "accessed": "2026-11-04",
      "rights_note": "Internal source locator; inherited claims remain provisional until corroborated."
    }
  ],
  "synthetic_episode": {
    "calendar_frame": "modern_shifted",
    "index_date": "2026-06-29",
    "index_age": 54,
    "date_shift_policy": "HR-DATE-SHIFT-1",
    "teaching_objective": "Recognize new progressive neurologic symptoms (morning headache, word-finding pauses and a clumsy hand) as a reason for prompt contrast MRI of the brain in a 54-year-old Black woman who survived childhood polio, and then manage a newly diagnosed glioblastoma to current standards: dexamethasone only for symptomatic edema, at the lowest dose and tapered early, with glucose and stomach protection; no seizure prophylaxis when no seizure has occurred; CT to exclude another primary; awake craniotomy with language and motor mapping for maximal safe resection and an MRI within 48 hours; the WHO CNS5 2021 integrated diagnosis with IDH, TERT, EGFR, chromosome 7 and 10 and MGMT promoter methylation; radiotherapy 60 Gy in 30 fractions with daily temozolomide and Pneumocystis prophylaxis, then adjuvant temozolomide with tumor-treating fields; blood count and liver test monitoring; RANO 2.0 response assessment that allows for pseudoprogression; venous thromboembolism awareness; fall prevention for a woman whose new right-sided weakness meets a left leg weakened by polio in childhood; and early palliative care with advance care planning alongside treatment, on the NCCN CNS cancers guideline, the EANO 2021 diffuse glioma guideline and the ASCO-SNO glioma guideline. Her childhood care, given at a Black medical school because care nearer home was not offered to her, frames the commitment to equal access to a brain tumor center and clinical trials.",
    "visit_schedule": [
      {
        "encounter_id": "ENC-001",
        "date": "2026-06-29",
        "purpose": "New headaches, word-finding pauses and right-hand clumsiness in a woman of 54: neurologic examination, MRI of the brain booked for the next morning, and neuro-oncology review booked"
      },
      {
        "encounter_id": "ENC-002",
        "date": "2026-07-02",
        "purpose": "MRI result: left frontal mass with edema; dexamethasone, CT staging, neuro-oncology consultation with neurosurgery, and preparation for awake craniotomy"
      },
      {
        "encounter_id": "ENC-003",
        "date": "2026-07-29",
        "purpose": "Review three weeks after awake craniotomy: pathology and molecular diagnosis, steroid taper, steroid-related hyperglycemia, falls, and the plan for radiotherapy with temozolomide"
      },
      {
        "encounter_id": "ENC-004",
        "date": "2026-09-14",
        "purpose": "End of six weeks of radiotherapy with daily temozolomide: blood counts, liver tests, Pneumocystis prophylaxis, fatigue, mood, tumor-treating fields and an early palliative care referral"
      },
      {
        "encounter_id": "ENC-005",
        "date": "2026-10-09",
        "purpose": "Post-chemoradiation MRI result, day 1 of adjuvant temozolomide, the start of tumor-treating fields, and the palliative care plan"
      },
      {
        "encounter_id": "ENC-006",
        "date": "2026-10-29",
        "purpose": "Periodic adult preventive visit"
      }
    ]
  },
  "clinical": {
    "problems": [
      {
        "id": "PRB-001",
        "display": "Three weeks of headaches on waking, with ten days of pauses in finding words and clumsiness of the right hand, in a previously well woman of 54: an intracranial lesion must be excluded. MRI of the brain with and without contrast booked for tomorrow morning, and neuro-oncology review booked",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "R29.818",
            "display": "Other symptoms and signs involving the nervous system",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic presenting problem; no symptom of her real illness was made public. Superseded when the MRI showed a brain mass.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        },
        "clinical_status": "resolved",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "abatement_date": "2026-07-02"
      },
      {
        "id": "PRB-002",
        "display": "Left posterior frontal ring-enhancing mass, 3.8 cm, with central necrosis, surrounding edema and 5 mm midline shift, next to the language and motor areas; presumed high-grade glioma, with no primary cancer elsewhere on CT; tissue diagnosis pending",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "D49.6",
            "display": "Neoplasm of unspecified behavior of brain",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic imaging diagnosis before surgery; superseded by the pathology.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        },
        "clinical_status": "resolved",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "recorded_date": "2026-07-02",
        "abatement_date": "2026-07-29"
      },
      {
        "id": "PRB-003",
        "display": "Glioblastoma, IDH-wildtype, CNS WHO grade 4, left posterior frontal lobe, MGMT promoter methylated, after gross total resection of the enhancing tumor; synthetic modern detail linked to her publicly reported brain cancer",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "C71.1",
            "display": "Malignant neoplasm of frontal lobe",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic histology, molecular result and location; brain cancer is documented as the cause of her death (D), and nothing more about it was made public.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "both_with_link",
        "recorded_date": "2026-07-29"
      },
      {
        "id": "PRB-004",
        "display": "Late effects of childhood poliomyelitis: paralysis of the left leg in early childhood, treated with a metal brace, a special shoe, massage and heat, with full recovery of walking by about age 12 and a later career as an Olympic sprinter; no new weakness, fatigue or pain now to suggest post-polio syndrome",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "B91",
            "display": "Sequelae of poliomyelitis",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003",
            "CLM-0004",
            "CLM-0005",
            "CLM-0006"
          ],
          "synthetic_reason": "Documented childhood polio (D); the current absence of new symptoms is synthetic.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "both_with_link"
      },
      {
        "id": "PRB-005",
        "display": "Vasogenic cerebral edema around the left frontal mass, with 5 mm midline shift, causing headache and contributing to the language and right-hand symptoms; treated with dexamethasone",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "G93.6",
            "display": "Cerebral edema",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic finding on the first MRI.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        },
        "clinical_status": "resolved",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "recorded_date": "2026-07-02",
        "abatement_date": "2026-10-09"
      },
      {
        "id": "PRB-006",
        "display": "Steroid-induced hyperglycemia on dexamethasone: random glucose 168 mg/dL, with an A1c of 5.6% before steroids",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "R73.9",
            "display": "Hyperglycemia, unspecified",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic common effect of dexamethasone; resolved after the taper.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        },
        "clinical_status": "resolved",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "recorded_date": "2026-07-29",
        "abatement_date": "2026-09-14"
      },
      {
        "id": "PRB-007",
        "display": "Lymphopenia from temozolomide, grade 2 (absolute lymphocytes 0.5 x 10^3/uL at the end of chemoradiation): Pneumocystis prophylaxis continues until recovery to grade 1 or better",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "D72.810",
            "display": "Lymphocytopenia",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic common effect of daily temozolomide with radiotherapy.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "recorded_date": "2026-09-14"
      }
    ],
    "medications": [
      {
        "id": "MED-001",
        "display": "Acetaminophen 500 mg oral tablet, two tablets by mouth every 6 hours as needed for headache, no more than 3 g a day",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "198440",
            "display": "acetaminophen 500 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 2,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 6,
          "period_unit": "h",
          "text": "Two tablets every 6 hours as needed"
        },
        "start_date": "2026-06-29",
        "indication_problem_ids": [
          "PRB-001"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic headache relief; nonsteroidal anti-inflammatory drugs avoided before possible surgery.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "MED-002",
        "display": "Dexamethasone 4 mg oral tablet, one tablet twice a day with food, for symptomatic vasogenic edema, until surgery",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "197582",
            "display": "dexamethasone 4 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 12,
          "period_unit": "h",
          "text": "One tablet twice a day with breakfast and lunch"
        },
        "start_date": "2026-06-30",
        "end_date": "2026-07-08",
        "indication_problem_ids": [
          "PRB-005"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic steroid started by telephone on the evening of the MRI for edema causing symptoms.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "MED-003",
        "display": "Famotidine 20 mg oral tablet, one tablet twice a day while taking dexamethasone",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "310273",
            "display": "famotidine 20 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 12,
          "period_unit": "h",
          "text": "One tablet twice a day"
        },
        "start_date": "2026-06-30",
        "end_date": "2026-08-12",
        "indication_problem_ids": [
          "PRB-005"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic stomach protection while on dexamethasone.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "MED-004",
        "display": "Dexamethasone 2 mg oral tablet, one tablet twice a day after surgery, tapering",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "197581",
            "display": "dexamethasone 2 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 12,
          "period_unit": "h",
          "text": "One tablet twice a day"
        },
        "start_date": "2026-07-10",
        "end_date": "2026-07-29",
        "indication_problem_ids": [
          "PRB-005"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic postoperative steroid taper after the inpatient doses.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "MED-005",
        "display": "Dexamethasone 2 mg oral tablet: one tablet daily for one week, then half a tablet daily for one week, then stop",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "197581",
            "display": "dexamethasone 2 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet daily for a week, then half a tablet daily for a week"
        },
        "start_date": "2026-07-29",
        "end_date": "2026-08-12",
        "indication_problem_ids": [
          "PRB-005"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic end of the steroid taper.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "MED-006",
        "display": "Temozolomide 140 mg oral capsule, 140 mg (75 mg/m2) by mouth daily at bedtime on an empty stomach, seven days a week for 42 days from the first day of radiotherapy",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "700883",
            "display": "temozolomide 140 MG Oral Capsule",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 140,
          "unit": "mg"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "Once daily at bedtime, seven days a week, for 42 days"
        },
        "start_date": "2026-08-03",
        "end_date": "2026-09-13",
        "indication_problem_ids": [
          "PRB-003"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic concurrent temozolomide (Stupp protocol); body surface area 1.84 m2.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "MED-007",
        "display": "Sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet, one tablet three times a week (Monday, Wednesday and Friday) to prevent Pneumocystis pneumonia",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "198335",
            "display": "sulfamethoxazole 800 MG / trimethoprim 160 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "wk",
          "text": "One tablet on Monday, Wednesday and Friday"
        },
        "start_date": "2026-08-03",
        "indication_problem_ids": [
          "PRB-003"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic Pneumocystis prophylaxis during concurrent temozolomide, continued while lymphopenia lasts.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "MED-008",
        "display": "Ondansetron 8 mg oral tablet, one tablet 30 to 60 minutes before each temozolomide dose, and every 8 hours as needed for nausea",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "312086",
            "display": "ondansetron 8 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 8,
          "period_unit": "h",
          "text": "Before each temozolomide dose; every 8 hours as needed"
        },
        "start_date": "2026-08-03",
        "indication_problem_ids": [
          "PRB-003"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic antiemetic for temozolomide.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "MED-009",
        "display": "Temozolomide 140 mg oral capsule, 280 mg (150 mg/m2) by mouth at bedtime on days 1 to 5 of each 28-day cycle, adjuvant cycle 1 of 6",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "700883",
            "display": "temozolomide 140 MG Oral Capsule",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "dose": {
          "value": 280,
          "unit": "mg"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "Two capsules once daily at bedtime on days 1 to 5 of each 28-day cycle"
        },
        "start_date": "2026-10-09",
        "indication_problem_ids": [
          "PRB-003"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic adjuvant temozolomide; cycle 1 at 150 mg/m2, with escalation to 200 mg/m2 from cycle 2 if counts allow.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      }
    ],
    "allergies": [
      {
        "id": "ALG-001",
        "display": "No known allergy",
        "status": "active",
        "assertion": "no_known_allergy",
        "substance": {
          "system": "http://snomed.info/sct",
          "code": "716186003",
          "display": "No known allergy"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic allergy assertion for EHR completeness; not a historical assertion.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      }
    ],
    "observations": [
      {
        "id": "OBS-HGB-V1",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-29",
        "value": 13.1,
        "unit": "g/dL",
        "reference_range": {
          "low": 12.0,
          "high": 15.5
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count at presentation; normal. No result from her life was made public.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "OBS-WBC-V1",
        "display": "Leukocytes [#/volume] in Blood by Automated count",
        "label": "White cell count",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-29",
        "value": 7.1,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 4.0,
          "high": 11.0
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6690-2",
            "display": "Leukocytes [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count at presentation; normal. No result from her life was made public.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "OBS-PLT-V1",
        "display": "Platelets [#/volume] in Blood by Automated count",
        "label": "Platelets",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-29",
        "value": 262,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 150,
          "high": 400
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "777-3",
            "display": "Platelets [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count at presentation; normal. No result from her life was made public.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "OBS-NA-V1",
        "display": "Sodium [Moles/volume] in Serum or Plasma",
        "label": "Sodium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-29",
        "value": 139,
        "unit": "mmol/L",
        "reference_range": {
          "low": 135,
          "high": 145
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2951-2",
            "display": "Sodium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic electrolytes, kidney function and glucose at presentation; creatinine checked before contrast MRI.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "OBS-K-V1",
        "display": "Potassium [Moles/volume] in Serum or Plasma",
        "label": "Potassium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-29",
        "value": 4.2,
        "unit": "mmol/L",
        "reference_range": {
          "low": 3.5,
          "high": 5.1
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2823-3",
            "display": "Potassium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic electrolytes, kidney function and glucose at presentation; creatinine checked before contrast MRI.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V1",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-29",
        "value": 0.86,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.59,
          "high": 1.04
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic electrolytes, kidney function and glucose at presentation; creatinine checked before contrast MRI.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V1",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR (CKD-EPI 2021)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-29",
        "value": 80,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic electrolytes, kidney function and glucose at presentation; creatinine checked before contrast MRI.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "OBS-GLU-V1",
        "display": "Glucose [Mass/volume] in Serum or Plasma",
        "label": "Glucose",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-29",
        "value": 92,
        "unit": "mg/dL",
        "reference_range": {
          "low": 70,
          "high": 99
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2345-7",
            "display": "Glucose [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic electrolytes, kidney function and glucose at presentation; creatinine checked before contrast MRI.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "OBS-A1C-V1",
        "display": "Hemoglobin A1c/Hemoglobin.total in Blood",
        "label": "Hemoglobin A1c",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-29",
        "value": 5.6,
        "unit": "%",
        "reference_range": {
          "high": 5.6,
          "text": "Below 5.7% is normal; 5.7 to 6.4% prediabetes"
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "4548-4",
            "display": "Hemoglobin A1c/Hemoglobin.total in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic A1c before any steroid, as a baseline for steroid-related hyperglycemia.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "OBS-KPS-V1",
        "display": "Karnofsky Performance Status score",
        "label": "Karnofsky Performance Status",
        "status": "final",
        "effective_date": "2026-06-29",
        "value": 80,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "89243-0",
            "display": "Karnofsky Performance Status score",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic Karnofsky score: normal activity with effort, some symptoms. Not a claim about her real function.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ2-V1",
        "display": "Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]",
        "label": "PHQ-2",
        "status": "final",
        "effective_date": "2026-06-29",
        "value": 1,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "55758-7",
            "display": "Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic depression screen; negative. Not a claim about her real mood.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "OBS-HGB-V2",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-02",
        "value": 13.0,
        "unit": "g/dL",
        "reference_range": {
          "low": 12.0,
          "high": 15.5
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic preoperative blood count; white cells raised by dexamethasone.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "OBS-WBC-V2",
        "display": "Leukocytes [#/volume] in Blood by Automated count",
        "label": "White cell count",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-02",
        "value": 11.8,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 4.0,
          "high": 11.0
        },
        "interpretation": "H",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6690-2",
            "display": "Leukocytes [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic preoperative blood count; white cells raised by dexamethasone.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "OBS-PLT-V2",
        "display": "Platelets [#/volume] in Blood by Automated count",
        "label": "Platelets",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-02",
        "value": 270,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 150,
          "high": 400
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "777-3",
            "display": "Platelets [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic preoperative blood count; white cells raised by dexamethasone.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "OBS-NA-V2",
        "display": "Sodium [Moles/volume] in Serum or Plasma",
        "label": "Sodium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-02",
        "value": 140,
        "unit": "mmol/L",
        "reference_range": {
          "low": 135,
          "high": 145
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2951-2",
            "display": "Sodium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic preoperative chemistry; non-fasting glucose raised on dexamethasone.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "OBS-K-V2",
        "display": "Potassium [Moles/volume] in Serum or Plasma",
        "label": "Potassium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-02",
        "value": 4.0,
        "unit": "mmol/L",
        "reference_range": {
          "low": 3.5,
          "high": 5.1
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2823-3",
            "display": "Potassium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic preoperative chemistry; non-fasting glucose raised on dexamethasone.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V2",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-02",
        "value": 0.84,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.59,
          "high": 1.04
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic preoperative chemistry; non-fasting glucose raised on dexamethasone.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V2",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR (CKD-EPI 2021)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-02",
        "value": 83,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic preoperative chemistry; non-fasting glucose raised on dexamethasone.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "OBS-GLU-V2",
        "display": "Glucose [Mass/volume] in Serum or Plasma",
        "label": "Glucose",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-02",
        "value": 138,
        "unit": "mg/dL",
        "reference_range": {
          "low": 70,
          "high": 99
        },
        "interpretation": "H",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2345-7",
            "display": "Glucose [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic preoperative chemistry; non-fasting glucose raised on dexamethasone.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "OBS-INR-V2",
        "display": "INR in Platelet poor plasma by Coagulation assay",
        "label": "INR",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-02",
        "value": 1.0,
        "unit": "{INR}",
        "reference_range": {
          "low": 0.9,
          "high": 1.1
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6301-6",
            "display": "INR in Platelet poor plasma by Coagulation assay",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic preoperative INR.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "OBS-APTT-V2",
        "display": "aPTT in Blood by Coagulation assay",
        "label": "aPTT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-02",
        "value": 29,
        "unit": "s",
        "reference_range": {
          "low": 25,
          "high": 37
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "3173-2",
            "display": "aPTT in Blood by Coagulation assay",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic preoperative aPTT.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "OBS-KPS-V2",
        "display": "Karnofsky Performance Status score",
        "label": "Karnofsky Performance Status",
        "status": "final",
        "effective_date": "2026-07-02",
        "value": 80,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "89243-0",
            "display": "Karnofsky Performance Status score",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic Karnofsky score on dexamethasone.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V2",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-07-02",
        "value": 7,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic PHQ-9 on the day the MRI was explained; item 9 scored 0. Not a claim about her real mood.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "OBS-GAD7-V2",
        "display": "Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]",
        "label": "GAD-7",
        "status": "final",
        "effective_date": "2026-07-02",
        "value": 9,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "70274-6",
            "display": "Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic GAD-7 on the day the MRI was explained.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "OBS-HGB-V3",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-29",
        "value": 12.6,
        "unit": "g/dL",
        "reference_range": {
          "low": 12.0,
          "high": 15.5
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic baseline blood count before temozolomide.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "OBS-WBC-V3",
        "display": "Leukocytes [#/volume] in Blood by Automated count",
        "label": "White cell count",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-29",
        "value": 9.6,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 4.0,
          "high": 11.0
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6690-2",
            "display": "Leukocytes [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic baseline blood count before temozolomide.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "OBS-ANC-V3",
        "display": "Neutrophils [#/volume] in Blood by Automated count",
        "label": "Absolute neutrophil count",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-29",
        "value": 7.2,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 1.5,
          "high": 7.7
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "751-8",
            "display": "Neutrophils [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic baseline blood count before temozolomide.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "OBS-LYMPH-V3",
        "display": "Lymphocytes [#/volume] in Blood by Automated count",
        "label": "Absolute lymphocyte count",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-29",
        "value": 1.1,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 1.0,
          "high": 4.0
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "731-0",
            "display": "Lymphocytes [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic baseline blood count before temozolomide.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "OBS-PLT-V3",
        "display": "Platelets [#/volume] in Blood by Automated count",
        "label": "Platelets",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-29",
        "value": 248,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 150,
          "high": 400
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "777-3",
            "display": "Platelets [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic baseline blood count before temozolomide.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V3",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-29",
        "value": 0.82,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.59,
          "high": 1.04
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic baseline kidney and liver tests before temozolomide; random glucose raised on dexamethasone.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V3",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR (CKD-EPI 2021)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-29",
        "value": 85,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic baseline kidney and liver tests before temozolomide; random glucose raised on dexamethasone.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V3",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-29",
        "value": 28,
        "unit": "U/L",
        "reference_range": {
          "low": 7,
          "high": 35
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic baseline kidney and liver tests before temozolomide; random glucose raised on dexamethasone.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "OBS-AST-V3",
        "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "AST",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-29",
        "value": 22,
        "unit": "U/L",
        "reference_range": {
          "low": 8,
          "high": 35
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1920-8",
            "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic baseline kidney and liver tests before temozolomide; random glucose raised on dexamethasone.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "OBS-TBIL-V3",
        "display": "Bilirubin.total [Mass/volume] in Serum or Plasma",
        "label": "Total bilirubin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-29",
        "value": 0.5,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.1,
          "high": 1.2
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1975-2",
            "display": "Bilirubin.total [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic baseline kidney and liver tests before temozolomide; random glucose raised on dexamethasone.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALB-V3",
        "display": "Albumin [Mass/volume] in Serum or Plasma",
        "label": "Albumin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-29",
        "value": 4.0,
        "unit": "g/dL",
        "reference_range": {
          "low": 3.5,
          "high": 5.0
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1751-7",
            "display": "Albumin [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic baseline kidney and liver tests before temozolomide; random glucose raised on dexamethasone.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "OBS-GLU-V3",
        "display": "Glucose [Mass/volume] in Serum or Plasma",
        "label": "Glucose",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-29",
        "value": 168,
        "unit": "mg/dL",
        "reference_range": {
          "low": 70,
          "high": 99
        },
        "interpretation": "H",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2345-7",
            "display": "Glucose [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic baseline kidney and liver tests before temozolomide; random glucose raised on dexamethasone.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "OBS-KPS-V3",
        "display": "Karnofsky Performance Status score",
        "label": "Karnofsky Performance Status",
        "status": "final",
        "effective_date": "2026-07-29",
        "value": 90,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "89243-0",
            "display": "Karnofsky Performance Status score",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic Karnofsky score three weeks after surgery.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V3",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-07-29",
        "value": 6,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic PHQ-9; item 9 scored 0.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "OBS-HGB-V4",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-09-14",
        "value": 11.9,
        "unit": "g/dL",
        "reference_range": {
          "low": 12.0,
          "high": 15.5
        },
        "interpretation": "L",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count at the end of chemoradiation: grade 1 thrombocytopenia and grade 2 lymphopenia from temozolomide.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "OBS-WBC-V4",
        "display": "Leukocytes [#/volume] in Blood by Automated count",
        "label": "White cell count",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-09-14",
        "value": 3.6,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 4.0,
          "high": 11.0
        },
        "interpretation": "L",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6690-2",
            "display": "Leukocytes [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count at the end of chemoradiation: grade 1 thrombocytopenia and grade 2 lymphopenia from temozolomide.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "OBS-ANC-V4",
        "display": "Neutrophils [#/volume] in Blood by Automated count",
        "label": "Absolute neutrophil count",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-09-14",
        "value": 2.4,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 1.5,
          "high": 7.7
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "751-8",
            "display": "Neutrophils [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count at the end of chemoradiation: grade 1 thrombocytopenia and grade 2 lymphopenia from temozolomide.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "OBS-LYMPH-V4",
        "display": "Lymphocytes [#/volume] in Blood by Automated count",
        "label": "Absolute lymphocyte count",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-09-14",
        "value": 0.5,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 1.0,
          "high": 4.0
        },
        "interpretation": "L",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "731-0",
            "display": "Lymphocytes [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count at the end of chemoradiation: grade 1 thrombocytopenia and grade 2 lymphopenia from temozolomide.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "OBS-PLT-V4",
        "display": "Platelets [#/volume] in Blood by Automated count",
        "label": "Platelets",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-09-14",
        "value": 112,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 150,
          "high": 400
        },
        "interpretation": "L",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "777-3",
            "display": "Platelets [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count at the end of chemoradiation: grade 1 thrombocytopenia and grade 2 lymphopenia from temozolomide.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V4",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-09-14",
        "value": 0.8,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.59,
          "high": 1.04
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic kidney and liver tests at the end of chemoradiation; grade 1 transaminase rise; glucose normal off dexamethasone.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V4",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR (CKD-EPI 2021)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-09-14",
        "value": 88,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic kidney and liver tests at the end of chemoradiation; grade 1 transaminase rise; glucose normal off dexamethasone.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V4",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-09-14",
        "value": 48,
        "unit": "U/L",
        "reference_range": {
          "low": 7,
          "high": 35
        },
        "interpretation": "H",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic kidney and liver tests at the end of chemoradiation; grade 1 transaminase rise; glucose normal off dexamethasone.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "OBS-AST-V4",
        "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "AST",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-09-14",
        "value": 39,
        "unit": "U/L",
        "reference_range": {
          "low": 8,
          "high": 35
        },
        "interpretation": "H",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1920-8",
            "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic kidney and liver tests at the end of chemoradiation; grade 1 transaminase rise; glucose normal off dexamethasone.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "OBS-TBIL-V4",
        "display": "Bilirubin.total [Mass/volume] in Serum or Plasma",
        "label": "Total bilirubin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-09-14",
        "value": 0.6,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.1,
          "high": 1.2
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1975-2",
            "display": "Bilirubin.total [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic kidney and liver tests at the end of chemoradiation; grade 1 transaminase rise; glucose normal off dexamethasone.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "OBS-GLU-V4",
        "display": "Glucose [Mass/volume] in Serum or Plasma",
        "label": "Glucose",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-09-14",
        "value": 96,
        "unit": "mg/dL",
        "reference_range": {
          "low": 70,
          "high": 99
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2345-7",
            "display": "Glucose [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic kidney and liver tests at the end of chemoradiation; grade 1 transaminase rise; glucose normal off dexamethasone.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "OBS-KPS-V4",
        "display": "Karnofsky Performance Status score",
        "label": "Karnofsky Performance Status",
        "status": "final",
        "effective_date": "2026-09-14",
        "value": 80,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "89243-0",
            "display": "Karnofsky Performance Status score",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic Karnofsky score at the end of chemoradiation, with fatigue.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V4",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-09-14",
        "value": 8,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic PHQ-9; item 9 scored 0; fatigue and sleep items account for most of the score.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "OBS-HGB-V5",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-09",
        "value": 12.2,
        "unit": "g/dL",
        "reference_range": {
          "low": 12.0,
          "high": 15.5
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count before adjuvant cycle 1; counts allow the cycle; lymphopenia persists.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "OBS-WBC-V5",
        "display": "Leukocytes [#/volume] in Blood by Automated count",
        "label": "White cell count",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-09",
        "value": 4.4,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 4.0,
          "high": 11.0
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6690-2",
            "display": "Leukocytes [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count before adjuvant cycle 1; counts allow the cycle; lymphopenia persists.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "OBS-ANC-V5",
        "display": "Neutrophils [#/volume] in Blood by Automated count",
        "label": "Absolute neutrophil count",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-09",
        "value": 2.9,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 1.5,
          "high": 7.7
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "751-8",
            "display": "Neutrophils [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count before adjuvant cycle 1; counts allow the cycle; lymphopenia persists.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "OBS-LYMPH-V5",
        "display": "Lymphocytes [#/volume] in Blood by Automated count",
        "label": "Absolute lymphocyte count",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-09",
        "value": 0.6,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 1.0,
          "high": 4.0
        },
        "interpretation": "L",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "731-0",
            "display": "Lymphocytes [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count before adjuvant cycle 1; counts allow the cycle; lymphopenia persists.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "OBS-PLT-V5",
        "display": "Platelets [#/volume] in Blood by Automated count",
        "label": "Platelets",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-09",
        "value": 168,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 150,
          "high": 400
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "777-3",
            "display": "Platelets [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count before adjuvant cycle 1; counts allow the cycle; lymphopenia persists.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V5",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-09",
        "value": 0.81,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.59,
          "high": 1.04
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic kidney and liver tests before adjuvant cycle 1; transaminases back in range.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V5",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR (CKD-EPI 2021)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-09",
        "value": 86,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic kidney and liver tests before adjuvant cycle 1; transaminases back in range.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V5",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-09",
        "value": 31,
        "unit": "U/L",
        "reference_range": {
          "low": 7,
          "high": 35
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic kidney and liver tests before adjuvant cycle 1; transaminases back in range.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "OBS-AST-V5",
        "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "AST",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-09",
        "value": 27,
        "unit": "U/L",
        "reference_range": {
          "low": 8,
          "high": 35
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1920-8",
            "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic kidney and liver tests before adjuvant cycle 1; transaminases back in range.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "OBS-TBIL-V5",
        "display": "Bilirubin.total [Mass/volume] in Serum or Plasma",
        "label": "Total bilirubin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-09",
        "value": 0.5,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.1,
          "high": 1.2
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1975-2",
            "display": "Bilirubin.total [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic kidney and liver tests before adjuvant cycle 1; transaminases back in range.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "OBS-GLU-V5",
        "display": "Glucose [Mass/volume] in Serum or Plasma",
        "label": "Glucose",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-09",
        "value": 91,
        "unit": "mg/dL",
        "reference_range": {
          "low": 70,
          "high": 99
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2345-7",
            "display": "Glucose [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic kidney and liver tests before adjuvant cycle 1; transaminases back in range.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "OBS-KPS-V5",
        "display": "Karnofsky Performance Status score",
        "label": "Karnofsky Performance Status",
        "status": "final",
        "effective_date": "2026-10-09",
        "value": 80,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "89243-0",
            "display": "Karnofsky Performance Status score",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic Karnofsky score before adjuvant temozolomide.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V5",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-10-09",
        "value": 6,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic PHQ-9; item 9 scored 0.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "OBS-HGB-V6",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-29",
        "value": 11.8,
        "unit": "g/dL",
        "reference_range": {
          "low": 12.0,
          "high": 15.5
        },
        "interpretation": "L",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic day-21 blood count of adjuvant cycle 1.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:30:00-05:00"
        }
      },
      {
        "id": "OBS-WBC-V6",
        "display": "Leukocytes [#/volume] in Blood by Automated count",
        "label": "White cell count",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-29",
        "value": 3.4,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 4.0,
          "high": 11.0
        },
        "interpretation": "L",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6690-2",
            "display": "Leukocytes [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic day-21 blood count.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:30:00-05:00"
        }
      },
      {
        "id": "OBS-ANC-V6",
        "display": "Neutrophils [#/volume] in Blood by Automated count",
        "label": "Absolute neutrophil count",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-29",
        "value": 1.9,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 1.5,
          "high": 7.7
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "751-8",
            "display": "Neutrophils [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic day-21 neutrophils; above the threshold for the next cycle.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:30:00-05:00"
        }
      },
      {
        "id": "OBS-LYMPH-V6",
        "display": "Lymphocytes [#/volume] in Blood by Automated count",
        "label": "Absolute lymphocyte count",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-29",
        "value": 0.6,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 1.0,
          "high": 4.0
        },
        "interpretation": "L",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "731-0",
            "display": "Lymphocytes [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic lymphocytes; grade 2 lymphopenia persists.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:30:00-05:00"
        }
      },
      {
        "id": "OBS-PLT-V6",
        "display": "Platelets [#/volume] in Blood by Automated count",
        "label": "Platelets",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-29",
        "value": 121,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 150,
          "high": 400
        },
        "interpretation": "L",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "777-3",
            "display": "Platelets [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic day-21 platelets; grade 1, above the threshold for the next cycle.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:30:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V6",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-29",
        "value": 33,
        "unit": "U/L",
        "reference_range": {
          "low": 7,
          "high": 35
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic cycle 1 liver test, drawn with the day-21 count.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:30:00-05:00"
        }
      },
      {
        "id": "OBS-AST-V6",
        "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "AST",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-29",
        "value": 29,
        "unit": "U/L",
        "reference_range": {
          "low": 8,
          "high": 35
        },
        "interpretation": "N",
        "panel": {
          "code": "24323-8",
          "display": "Comprehensive metabolic 2000 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1920-8",
            "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic cycle 1 liver test.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:30:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ2-V6",
        "display": "Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]",
        "label": "PHQ-2",
        "status": "final",
        "effective_date": "2026-10-29",
        "value": 1,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "55758-7",
            "display": "Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic depression screen; negative. Not a claim about her real mood.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:30:00-05:00"
        }
      }
    ],
    "procedures": [
      {
        "id": "PROC-001",
        "display": "MRI of the brain with and without contrast, with diffusion and perfusion: a 3.8 x 3.2 cm ring-enhancing mass in the left posterior frontal lobe, involving the posterior inferior frontal gyrus and abutting the precentral gyrus, with central necrosis, raised relative cerebral blood volume in the enhancing rim, no restricted diffusion in the necrotic center, surrounding FLAIR signal from edema, and 5 mm rightward midline shift; no other lesion",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "16327691000119101",
            "display": "MRI of brain with contrast",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-06-30",
          "end": "2026-06-30"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic imaging the morning after the first visit.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "PROC-002",
        "display": "CT of the chest, abdomen and pelvis with contrast to look for a primary cancer elsewhere: no mass, enlarged lymph node or other lesion",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "418023006",
            "display": "CT of chest, abdomen and pelvis",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-07-01",
          "end": "2026-07-01"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic staging scan, because a ring-enhancing mass can be a metastasis.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "PROC-003",
        "display": "Functional MRI with diffusion tensor tractography for surgical planning: left-hemisphere language dominance; expressive language activation just in front of the mass; the corticospinal tract displaced but intact",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "241603006",
            "display": "MRI of brain with functional imaging",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-07-06",
          "end": "2026-07-06"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic presurgical mapping.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "PROC-004",
        "display": "Awake left frontal craniotomy with cortical and subcortical language and motor mapping and fluorescence-guided resection: gross total resection of the enhancing tumor, stopped at the mapped language sites. Pathology: glioblastoma, IDH-wildtype, CNS WHO grade 4 (necrosis and microvascular proliferation; IDH1 R132H immunostain negative and no IDH1 or IDH2 mutation on sequencing; ATRX retained; TERT promoter mutation; EGFR amplification; gain of chromosome 7 and loss of chromosome 10; CDKN2A homozygous deletion; histone H3 and BRAF wild-type). MGMT promoter methylated by pyrosequencing. Inpatient stay of three days, with mechanical and then low-molecular-weight heparin prophylaxis against venous thromboembolism from the day after surgery",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "447107001",
            "display": "Craniotomy and excision of neoplasm of brain",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-07-08",
          "end": "2026-07-08"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic operation and pathology; nothing about her real treatment was made public.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "PROC-005",
        "display": "MRI of the brain with and without contrast within 48 hours of surgery: no residual enhancing tumor; expected postoperative blood products; small area of restricted diffusion at the posterior margin from surgery; edema and midline shift less",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "16327691000119101",
            "display": "MRI of brain with contrast",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-07-09",
          "end": "2026-07-09"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic postoperative baseline MRI.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "PROC-006",
        "display": "Outpatient physical therapy assessment: mild weakness of the right hand and hip flexors after surgery; the left calf, weakened by polio in childhood, slightly smaller than the right with full strength; Timed Up and Go 9 seconds; home exercise program, home safety review and a fall plan",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "410158009",
            "display": "Physical therapy assessment",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-07-22",
          "end": "2026-07-22"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic rehabilitation assessment two weeks after surgery.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "PROC-007",
        "display": "External beam radiotherapy to the resection cavity and margin, 60 Gy in 30 daily fractions over six weeks, with daily temozolomide; given in full on schedule",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "33195004",
            "display": "External beam radiation therapy procedure",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-08-03",
          "end": "2026-09-11"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic standard radiotherapy for glioblastoma.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "PROC-008",
        "display": "Outpatient palliative care consultation alongside cancer treatment: symptoms, coping, her understanding of the illness, goals and wishes, support for her family, and advance care planning; she named a health care agent (recorded in the confidential part of the chart) and completed an advance directive",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "103735009",
            "display": "Palliative care",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-09-28",
          "end": "2026-09-28"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic early palliative care, as current guidance recommends for glioblastoma.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "PROC-009",
        "display": "MRI of the brain with and without contrast four weeks after chemoradiation: thin, smooth enhancement along the resection cavity with no nodular or new enhancement; FLAIR change around the cavity slightly less than after surgery; no new lesion. Treatment-related change; no progression (RANO 2.0); this scan is the new baseline",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "16327691000119101",
            "display": "MRI of brain with contrast",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-10-07",
          "end": "2026-10-07"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic post-chemoradiation MRI.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "PROC-010",
        "display": "Advance care planning conversation, about 20 minutes, reviewing the advance directive completed with palliative care",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "713603004",
            "display": "Advance care planning",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "period": {
          "start": "2026-10-29",
          "end": "2026-10-29"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic voluntary advance care planning; records only her own general preferences.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:30:00-05:00"
        }
      }
    ],
    "immunizations": [
      {
        "id": "IMM-001",
        "display": "Influenza vaccine, inactivated, trivalent, preservative free, this season",
        "status": "completed",
        "date": "2026-10-29",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "140",
            "display": "Influenza, split virus, trivalent, PF",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seasonal influenza vaccine; inactivated vaccines are safe during chemotherapy.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:30:00-05:00"
        }
      },
      {
        "id": "IMM-002",
        "display": "Pneumococcal conjugate vaccine PCV20",
        "status": "completed",
        "date": "2026-10-29",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "216",
            "display": "Pneumococcal conjugate PCV20, polysaccharide CRM197 conjugate, adjuvant, PF",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic single dose: recommended for every adult from 50, and she is immunocompromised by chemotherapy.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:30:00-05:00"
        }
      },
      {
        "id": "IMM-003",
        "display": "Recombinant zoster vaccine, dose 1 of 2",
        "status": "completed",
        "date": "2026-10-29",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "187",
            "display": "zoster recombinant",
            "validation_status": "validated",
            "validated_on": "2026-11-04"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic first dose for an adult over 50 who is immunocompromised; second dose in one to two months.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:30:00-05:00"
        }
      }
    ],
    "family_history": [],
    "past_medical_history": [
      {
        "id": "PMH-001",
        "display": "Born prematurely, weighing about 4.5 pounds",
        "historical_date": {
          "iso": "1940-06-23",
          "display": "June 23, 1940",
          "precision": "day",
          "calendar": "gregorian"
        },
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0002"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "PMH-002",
        "display": "Double pneumonia followed by scarlet fever at about age four, among other childhood illnesses",
        "historical_date": {
          "iso": "1944",
          "display": "about 1944",
          "precision": "year",
          "calendar": "gregorian"
        },
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0003"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "PMH-003",
        "display": "Poliomyelitis in early childhood, leaving the left leg paralyzed or partly paralyzed, with the foot turned inward",
        "historical_date": {
          "iso": "1945",
          "display": "about 1945",
          "precision": "year",
          "calendar": "gregorian"
        },
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0004"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "PMH-004",
        "display": "Metal leg brace and special shoe for several years; weekly treatment at Meharry Medical College in Nashville, with massage and heat, and massage at home several times a day",
        "historical_date": {
          "iso": "1946",
          "display": "about 1946",
          "precision": "year",
          "calendar": "gregorian"
        },
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "PMH-005",
        "display": "Walking without the brace by about age 12; later an Olympic sprinter",
        "historical_date": {
          "iso": "1952",
          "display": "about 1952",
          "precision": "year",
          "calendar": "gregorian"
        },
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0006",
            "CLM-0007"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      }
    ],
    "encounters": [
      {
        "id": "ENC-001",
        "display": "New headaches, word-finding pauses and right-hand clumsiness in a woman of 54: neurologic examination, MRI of the brain booked for the next morning, and neuro-oncology review booked",
        "status": "finished",
        "date": "2026-06-29",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "ENC-002",
        "display": "MRI result: left frontal mass with edema; dexamethasone, CT staging, neuro-oncology consultation with neurosurgery, and preparation for awake craniotomy",
        "status": "finished",
        "date": "2026-07-02",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-04"
        },
        "documentation": {
          "chief_complaint": "MRI result and neuro-oncology consultation",
          "hpi": {
            "narrative": "Ms. Rudolph returns three days after her first visit. The MRI the next morning showed a 3.8 cm ring-enhancing mass in the left posterior frontal lobe with central necrosis, surrounding edema and 5 mm of midline shift. Dr. Haynes-Whitaker telephoned her the same afternoon and started dexamethasone 4 mg twice a day with famotidine. Since then the morning headaches have eased and her words come more easily, though she still pauses now and then; the right hand is a little steadier. CT of the chest, abdomen and pelvis yesterday showed no cancer elsewhere. She has had no seizure, vomiting or drowsiness. She saw Dr. Brzezinski of neuro-oncology this morning, together with the neurosurgery team. She is not driving. She said that as a child she was told she would never walk, and that she wants the facts as they are. She has had no thoughts of self-harm.",
            "elements": [
              {
                "label": "MRI",
                "value": "3.8 cm ring-enhancing left posterior frontal mass with necrosis, edema and 5 mm midline shift; raised perfusion; no other lesion"
              },
              {
                "label": "CT body",
                "value": "No primary cancer elsewhere"
              },
              {
                "label": "Dexamethasone",
                "value": "4 mg twice a day for two days; headache and speech better"
              },
              {
                "label": "Coordination",
                "value": "Neuro-oncology and neurosurgery seen today; awake craniotomy planned in six days"
              },
              {
                "label": "Her questions",
                "value": "What the mass is, whether surgery can take it out without harming her speech or hand, and what comes after"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "negative",
              "finding": "No fever, night sweats or weight loss"
            },
            {
              "system": "Neurological",
              "status": "positive",
              "finding": "Occasional word-finding pauses, improving; right hand slightly clumsy; headache much less; no seizure"
            },
            {
              "system": "Eyes",
              "status": "negative",
              "finding": "No double vision"
            },
            {
              "system": "Gastrointestinal",
              "status": "negative",
              "finding": "No nausea, vomiting or heartburn"
            },
            {
              "system": "Endocrine",
              "status": "negative",
              "finding": "No thirst or frequent urination"
            },
            {
              "system": "Psychiatric",
              "status": "positive",
              "finding": "Worried and sleeping poorly since the call; PHQ-9 7 and GAD-7 9; no thoughts of self-harm"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well; weight 67.8 kg; blood pressure 134/82, pulse 78"
            },
            {
              "system": "Mental status and speech",
              "finding": "Alert and oriented; fluent with rare word-finding pauses; naming 15 of 15; repetition and comprehension intact"
            },
            {
              "system": "Cranial nerves",
              "finding": "Mild flattening of the right nasolabial fold; fundi without papilledema"
            },
            {
              "system": "Motor",
              "finding": "Slight right pronator drift; right grip and finger extension 4+/5; legs 5/5 on both sides"
            },
            {
              "system": "Gait",
              "finding": "Steady, normal stride; tandem gait slightly unsteady"
            },
            {
              "system": "Extremities",
              "finding": "Left calf slightly smaller than the right, from childhood polio; no leg swelling"
            },
            {
              "system": "Psychiatric",
              "finding": "Composed and direct; anxious when talking about her speech"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-002",
              "display": "Left posterior frontal ring-enhancing mass, presumed high-grade glioma",
              "assessment": "A single ring-enhancing mass with necrosis and raised perfusion in a woman of 54 with no cancer elsewhere on CT is most likely a high-grade glioma; a solitary metastasis, lymphoma or abscess is much less likely on the imaging. Tissue is needed for the diagnosis, and removing as much tumor as is safe improves outcome. Dr. Brzezinski and the neurosurgery team recommend an awake craniotomy with language and motor mapping in six days, after functional MRI with tractography. Fit for surgery: blood count, chemistry and clotting normal",
              "plan": [
                "Functional MRI with tractography in four days",
                "Awake craniotomy with mapping in six days; the operating team will explain the awake part in advance",
                "Tissue for the integrated WHO CNS5 diagnosis, including IDH, TERT, EGFR, chromosome 7 and 10 and MGMT promoter methylation"
              ]
            },
            {
              "problem_id": "PRB-005",
              "display": "Vasogenic cerebral edema with 5 mm midline shift",
              "assessment": "The edema, not the tumor alone, explains much of the headache and the speech and hand symptoms, and both are better on dexamethasone. Glucose 138 mg/dL (not fasting) and white cells 11.8 are the expected effects of the steroid. No antiseizure drug is needed because she has had no seizure",
              "plan": [
                "Continue dexamethasone 4 mg twice a day with famotidine until surgery, then taper",
                "Seizure first aid explained; call 911 for a seizure lasting more than five minutes"
              ]
            },
            {
              "problem_id": "PRB-001",
              "display": "New headache, word-finding pauses and right-hand clumsiness",
              "assessment": "Explained by the mass and edema found on MRI; superseded",
              "plan": [
                "Problem resolved"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "imaging",
              "measure": "MRI of the brain with and without contrast",
              "cadence": "At once for new progressive focal symptoms",
              "status": "up_to_date",
              "detail": "The morning after the first visit: ring-enhancing left frontal mass with necrosis, edema and midline shift",
              "guideline_ids": [
                "GL-NCCN-CNS-2026",
                "GL-EANO-GLIOMA-2021"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Advanced MRI sequences (diffusion and perfusion)",
              "cadence": "With the diagnostic MRI",
              "status": "up_to_date",
              "detail": "No restricted diffusion in the necrotic center (abscess unlikely); raised relative cerebral blood volume in the rim (high-grade tumor likely)",
              "guideline_ids": [
                "GL-NCCN-CNS-2026",
                "GL-EANO-GLIOMA-2021"
              ]
            },
            {
              "domain": "imaging",
              "measure": "CT of the chest, abdomen and pelvis",
              "cadence": "When a metastasis is possible",
              "status": "up_to_date",
              "detail": "Yesterday: no primary cancer elsewhere",
              "guideline_ids": [
                "GL-NCCN-CNS-2026",
                "GL-EANO-GLIOMA-2021"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Functional MRI with tractography",
              "cadence": "Before surgery near language or motor areas",
              "status": "ordered",
              "detail": "In four days",
              "guideline_ids": [
                "GL-NCCN-CNS-2026",
                "GL-EANO-GLIOMA-2021"
              ]
            },
            {
              "domain": "examination",
              "measure": "Neurologic examination (language, strength, gait)",
              "cadence": "Each visit",
              "status": "completed_today",
              "detail": "Rare word-finding pauses; slight right pronator drift; right grip 4+/5; better than at the first visit",
              "guideline_ids": [
                "GL-NCCN-CNS-2026",
                "GL-EANO-GLIOMA-2021"
              ]
            },
            {
              "domain": "survey",
              "measure": "Performance status (Karnofsky)",
              "cadence": "Each visit",
              "status": "completed_today",
              "detail": "Karnofsky 80",
              "observation_ids": [
                "OBS-KPS-V2"
              ],
              "guideline_ids": [
                "GL-NCCN-CNS-2026",
                "GL-EANO-GLIOMA-2021"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Dexamethasone: indication, dose and effects",
              "cadence": "When started and at each visit",
              "status": "completed_today",
              "detail": "Started for edema causing symptoms at 4 mg twice a day; glucose 138 mg/dL and white cells 11.8 on the steroid; famotidine for stomach protection; taper after surgery",
              "observation_ids": [
                "OBS-GLU-V2",
                "OBS-WBC-V2"
              ],
              "guideline_ids": [
                "GL-EANO-GLIOMA-2021",
                "GL-NCCN-CNS-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Preoperative blood count, chemistry and clotting",
              "cadence": "Within 30 days before surgery",
              "status": "completed_today",
              "detail": "Hemoglobin 13.0 g/dL, platelets 270; sodium 140, potassium 4.0, creatinine 0.84 mg/dL, eGFR 83; INR 1.0, aPTT 29 seconds",
              "observation_ids": [
                "OBS-HGB-V2",
                "OBS-PLT-V2",
                "OBS-NA-V2",
                "OBS-K-V2",
                "OBS-CR-V2",
                "OBS-EGFR-V2",
                "OBS-INR-V2",
                "OBS-APTT-V2"
              ],
              "guideline_ids": [
                "GL-NCCN-CNS-2026",
                "GL-EANO-GLIOMA-2021"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Seizure history and antiseizure drug need",
              "cadence": "At diagnosis and each visit",
              "status": "not_indicated",
              "detail": "No seizure has occurred, so no prophylactic antiseizure drug, as the SNO-EANO guideline advises",
              "guideline_ids": [
                "GL-SNO-EANO-AED-2021"
              ]
            },
            {
              "domain": "examination",
              "measure": "Signs of leg clot or pulmonary embolism",
              "cadence": "Each visit; brain tumors carry a high thrombosis risk",
              "status": "completed_today",
              "detail": "No leg swelling or breathlessness; hospital prophylaxis after surgery planned",
              "guideline_ids": [
                "GL-ASCO-VTE-2023"
              ]
            },
            {
              "domain": "referral",
              "measure": "Neuro-oncology and neurosurgery",
              "cadence": "Within a week of an MRI showing a probable brain tumor",
              "status": "completed_today",
              "detail": "Seen this morning; recommendations in the consultation note",
              "guideline_ids": [
                "GL-NCCN-CNS-2026",
                "GL-EANO-GLIOMA-2021"
              ]
            },
            {
              "domain": "survey",
              "measure": "Distress and depression screen (PHQ-9)",
              "cadence": "At diagnosis, each treatment phase, and when symptoms change",
              "status": "completed_today",
              "detail": "PHQ-9 7 and GAD-7 9, mild, with worry about the diagnosis; no thoughts of self-harm",
              "observation_ids": [
                "OBS-PHQ9-V2",
                "OBS-GAD7-V2"
              ],
              "guideline_ids": [
                "GL-USPSTF-DEP-2023",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Driving",
              "cadence": "From the first focal symptom",
              "status": "completed_today",
              "detail": "Not driving; reviewed again after surgery and treatment",
              "guideline_ids": [
                "GL-NCCN-CNS-2026",
                "GL-EANO-GLIOMA-2021"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Falls, leg strength and late effects of polio",
              "cadence": "Each visit",
              "status": "completed_today",
              "detail": "No falls; legs strong; uses the handrail on stairs while the right hand is weak",
              "guideline_ids": [
                "GL-EFNS-PPS-2006"
              ]
            }
          ],
          "follow_up": "Functional MRI in four days and surgery in six. Primary care review about three weeks after surgery with the pathology. Go to the emergency department for a seizure, worsening speech or weakness, vomiting or drowsiness",
          "guideline_ids": [
            "GL-NCCN-CNS-2026",
            "GL-EANO-GLIOMA-2021",
            "GL-WHO-CNS5-2021",
            "GL-SNO-EANO-AED-2021",
            "GL-ASCO-VTE-2023",
            "GL-EFNS-PPS-2006",
            "GL-USPSTF-DEP-2023",
            "GL-CMID-2026"
          ]
        }
      },
      {
        "id": "ENC-003",
        "display": "Review three weeks after awake craniotomy: pathology and molecular diagnosis, steroid taper, steroid-related hyperglycemia, falls, and the plan for radiotherapy with temozolomide",
        "status": "finished",
        "date": "2026-07-29",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-04"
        },
        "documentation": {
          "chief_complaint": "Review three weeks after awake craniotomy, before radiotherapy with temozolomide",
          "hpi": {
            "narrative": "Ms. Rudolph returns three weeks after an awake left frontal craniotomy. The surgeons removed all of the enhancing tumor, stopping at the mapped language sites, and the MRI the next day showed no residual enhancing tumor. Her speech was slower for three days after surgery and then came back to normal; she went home on the third day, having had heparin injections in hospital to prevent clots. She has had no seizure. The right hand is nearly back to normal, though fine buttons are still slow. The physical therapist saw her a week ago and gave her a home exercise program and a cane for uneven ground. She is now on dexamethasone 2 mg twice a day. Her fingerstick glucose readings at home have been 140 to 180 mg/dL after meals, and she is thirsty in the evenings. The pathology is glioblastoma, IDH-wildtype, with MGMT promoter methylation, and the tumor board has reviewed it with Dr. Brzezinski. She has met the radiation oncologist and had her planning scan, and starts radiotherapy with temozolomide on Monday. She has had no thoughts of self-harm.",
            "elements": [
              {
                "label": "Operation",
                "value": "Awake craniotomy with mapping; gross total resection of the enhancing tumor; home on day 3"
              },
              {
                "label": "Pathology",
                "value": "Glioblastoma, IDH-wildtype, CNS WHO grade 4; TERT promoter mutation, EGFR amplification, +7/-10; MGMT promoter methylated"
              },
              {
                "label": "Function",
                "value": "Speech normal; right hand nearly normal; walking well"
              },
              {
                "label": "Steroid",
                "value": "Dexamethasone 2 mg twice a day; glucose up to 180 mg/dL after meals"
              },
              {
                "label": "Next",
                "value": "Radiotherapy 60 Gy in 30 fractions with daily temozolomide from Monday"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "positive",
              "finding": "Tired in the afternoons; appetite larger on the steroid; weight up 1.6 kg"
            },
            {
              "system": "Neurological",
              "status": "positive",
              "finding": "Fine buttons slow with the right hand; no headache, seizure or speech difficulty"
            },
            {
              "system": "Endocrine",
              "status": "positive",
              "finding": "Thirsty in the evenings; glucose 140 to 180 mg/dL after meals"
            },
            {
              "system": "Musculoskeletal",
              "status": "negative",
              "finding": "No difficulty rising from a chair or climbing stairs"
            },
            {
              "system": "Integumentary",
              "status": "negative",
              "finding": "Incision healing; no redness or drainage"
            },
            {
              "system": "Cardiovascular",
              "status": "negative",
              "finding": "No leg swelling or calf pain"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Mood steadier; PHQ-9 6; no thoughts of self-harm"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well; weight 69.4 kg; blood pressure 132/80, pulse 76"
            },
            {
              "system": "Head",
              "finding": "Left frontal incision healed, staples out; no swelling or fluid collection"
            },
            {
              "system": "Mental status and speech",
              "finding": "Fluent, no word-finding pauses; naming and repetition intact"
            },
            {
              "system": "Motor",
              "finding": "No pronator drift; right grip 5-/5, finger tapping slightly slow; hip flexors 5/5 on both sides; rises from a chair without using her arms"
            },
            {
              "system": "Gait",
              "finding": "Steady; tandem gait normal"
            },
            {
              "system": "Extremities",
              "finding": "No leg swelling; calves soft; left calf slightly smaller than the right"
            },
            {
              "system": "Psychiatric",
              "finding": "Focused and well informed; asks detailed questions"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-003",
              "display": "Glioblastoma, IDH-wildtype, CNS WHO grade 4, left frontal, MGMT promoter methylated, after gross total resection",
              "assessment": "The integrated WHO CNS5 diagnosis is glioblastoma, IDH-wildtype: no IDH mutation on immunostaining or sequencing, with necrosis, microvascular proliferation, a TERT promoter mutation, EGFR amplification and chromosome 7 gain with 10 loss. MGMT promoter methylation and complete resection of the enhancing tumor in a fit woman of 54 are the most favorable factors this tumor has, and methylation predicts benefit from temozolomide. The tumor board recommends radiotherapy 60 Gy in 30 fractions with daily temozolomide 75 mg/m2 (140 mg for 1.84 m2), then six cycles of adjuvant temozolomide; tumor-treating fields will be discussed for the adjuvant phase. She was screened for open trials; none she was eligible for is open now. Baseline blood count, kidney and liver tests allow treatment. Hepatitis B, hepatitis C and HIV tests drawn today",
              "plan": [
                "Radiotherapy with temozolomide 140 mg at bedtime every day from Monday for six weeks",
                "Ondansetron 30 to 60 minutes before each dose",
                "Sulfamethoxazole-trimethoprim three times a week from the first day of temozolomide",
                "Blood count weekly at the radiation clinic",
                "Do not drive"
              ]
            },
            {
              "problem_id": "PRB-005",
              "display": "Vasogenic cerebral edema, better after resection",
              "assessment": "Edema and midline shift less on the postoperative MRI; no headache. The taper can continue",
              "plan": [
                "Dexamethasone 2 mg daily for one week, then 1 mg daily for one week, then stop",
                "Report headache, nausea or new weakness during the taper"
              ]
            },
            {
              "problem_id": "PRB-006",
              "display": "Steroid-induced hyperglycemia",
              "assessment": "Random glucose 168 mg/dL with home readings up to 180 after meals on dexamethasone, from an A1c of 5.6% before steroids: steroid-induced hyperglycemia, expected to resolve with the taper. No drug treatment is needed at these levels",
              "plan": [
                "Fingerstick glucose before supper daily until off dexamethasone",
                "Call for readings above 250 mg/dL",
                "Fewer sweet drinks and refined carbohydrates while on the steroid"
              ]
            },
            {
              "problem_id": "PRB-004",
              "display": "Late effects of childhood poliomyelitis",
              "assessment": "Legs strong on both sides and gait steady. The physical therapist found mild right-sided weakness after surgery on top of a left calf that was weakened by polio in childhood; her risk of falling is higher during treatment because of fatigue, steroid effects on muscle, and any change in the tumor",
              "plan": [
                "Home exercise program and a cane for uneven ground",
                "Leg strength at each visit"
              ]
            },
            {
              "problem_id": "PRB-002",
              "display": "Left frontal mass, presumed high-grade glioma",
              "assessment": "Superseded by the pathology",
              "plan": [
                "Problem resolved"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "laboratory",
              "measure": "Integrated WHO CNS5 diagnosis",
              "cadence": "On the surgical specimen",
              "status": "up_to_date",
              "detail": "Glioblastoma, IDH-wildtype, CNS WHO grade 4: IDH1 R132H negative and no IDH1 or IDH2 mutation on sequencing; ATRX retained; TERT promoter mutation; EGFR amplification; +7/-10; CDKN2A deleted; H3 and BRAF wild-type",
              "guideline_ids": [
                "GL-WHO-CNS5-2021",
                "GL-EANO-GLIOMA-2021",
                "GL-NCCN-CNS-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "MGMT promoter methylation",
              "cadence": "On the surgical specimen",
              "status": "up_to_date",
              "detail": "Methylated",
              "guideline_ids": [
                "GL-HEGI-2005",
                "GL-EANO-GLIOMA-2021",
                "GL-NCCN-CNS-2026"
              ]
            },
            {
              "domain": "imaging",
              "measure": "MRI within 48 hours of surgery",
              "cadence": "After resection, as the baseline for radiotherapy planning",
              "status": "up_to_date",
              "detail": "The day after surgery: no residual enhancing tumor",
              "guideline_ids": [
                "GL-RANO-2023",
                "GL-NCCN-CNS-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Blood count with neutrophils, lymphocytes and platelets",
              "cadence": "Baseline before temozolomide",
              "status": "completed_today",
              "detail": "Hemoglobin 12.6 g/dL, white cells 9.6, neutrophils 7.2, lymphocytes 1.1, platelets 248",
              "observation_ids": [
                "OBS-HGB-V3",
                "OBS-WBC-V3",
                "OBS-ANC-V3",
                "OBS-LYMPH-V3",
                "OBS-PLT-V3"
              ],
              "guideline_ids": [
                "GL-STUPP-2005",
                "GL-TMZ-LABEL",
                "GL-NCCN-CNS-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Kidney and liver tests",
              "cadence": "Baseline before temozolomide",
              "status": "completed_today",
              "detail": "Creatinine 0.82 mg/dL, eGFR 85; ALT 28, AST 22 U/L, bilirubin 0.5 mg/dL, albumin 4.0 g/dL",
              "observation_ids": [
                "OBS-CR-V3",
                "OBS-EGFR-V3",
                "OBS-ALT-V3",
                "OBS-AST-V3",
                "OBS-TBIL-V3",
                "OBS-ALB-V3"
              ],
              "guideline_ids": [
                "GL-TMZ-LABEL"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Glucose on dexamethasone",
              "cadence": "At each visit while on a steroid",
              "status": "completed_today",
              "detail": "168 mg/dL random; home readings 140 to 180 after meals",
              "observation_ids": [
                "OBS-GLU-V3"
              ],
              "guideline_ids": [
                "GL-EANO-GLIOMA-2021",
                "GL-NCCN-CNS-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Hepatitis B, hepatitis C and HIV screening",
              "cadence": "Before chemotherapy",
              "status": "ordered",
              "detail": "Drawn today",
              "guideline_ids": [
                "GL-NCCN-CNS-2026",
                "GL-EANO-GLIOMA-2021"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Dexamethasone taper",
              "cadence": "As soon as symptoms allow after surgery",
              "status": "completed_today",
              "detail": "2 mg twice a day now; 2 mg daily for a week, 1 mg daily for a week, then stop",
              "guideline_ids": [
                "GL-EANO-GLIOMA-2021",
                "GL-NCCN-CNS-2026"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Pneumocystis pneumonia prophylaxis",
              "cadence": "Throughout concurrent temozolomide",
              "status": "ordered",
              "detail": "Sulfamethoxazole-trimethoprim three times a week from the first day",
              "guideline_ids": [
                "GL-TMZ-LABEL"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Antiemetic before temozolomide",
              "cadence": "Each dose",
              "status": "ordered",
              "detail": "Ondansetron 30 to 60 minutes before the bedtime dose, on an empty stomach",
              "guideline_ids": [
                "GL-TMZ-LABEL"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Seizure history and antiseizure drug need",
              "cadence": "Each visit",
              "status": "not_indicated",
              "detail": "No seizure before or after surgery; no antiseizure drug",
              "guideline_ids": [
                "GL-SNO-EANO-AED-2021"
              ]
            },
            {
              "domain": "examination",
              "measure": "Neurologic examination (language, strength, gait)",
              "cadence": "Each visit",
              "status": "completed_today",
              "detail": "Speech normal; right grip 5-/5 with slightly slow finger tapping; gait steady",
              "guideline_ids": [
                "GL-NCCN-CNS-2026",
                "GL-EANO-GLIOMA-2021"
              ]
            },
            {
              "domain": "examination",
              "measure": "Signs of leg clot or pulmonary embolism",
              "cadence": "Each visit",
              "status": "completed_today",
              "detail": "No leg swelling or calf tenderness; hospital prophylaxis given after surgery; no routine prophylaxis at home",
              "guideline_ids": [
                "GL-ASCO-VTE-2023"
              ]
            },
            {
              "domain": "survey",
              "measure": "Performance status (Karnofsky)",
              "cadence": "Each visit",
              "status": "completed_today",
              "detail": "Karnofsky 90",
              "observation_ids": [
                "OBS-KPS-V3"
              ],
              "guideline_ids": [
                "GL-NCCN-CNS-2026",
                "GL-EANO-GLIOMA-2021"
              ]
            },
            {
              "domain": "referral",
              "measure": "Physical therapy",
              "cadence": "After surgery when weakness or fall risk is present",
              "status": "up_to_date",
              "detail": "Assessed a week ago: home program and a cane for uneven ground",
              "guideline_ids": [
                "GL-EFNS-PPS-2006"
              ]
            },
            {
              "domain": "referral",
              "measure": "Radiation oncology and clinical trial screening",
              "cadence": "After the integrated diagnosis",
              "status": "up_to_date",
              "detail": "Planning scan done; no eligible trial open",
              "guideline_ids": [
                "GL-NCCN-CNS-2026",
                "GL-EANO-GLIOMA-2021"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Falls, leg strength and late effects of polio",
              "cadence": "Each visit",
              "status": "completed_today",
              "detail": "No falls; legs 5/5; no new weakness, fatigue or pain in the polio-affected leg",
              "guideline_ids": [
                "GL-EFNS-PPS-2006"
              ]
            },
            {
              "domain": "survey",
              "measure": "Distress and depression screen (PHQ-9)",
              "cadence": "At diagnosis, each treatment phase, and when symptoms change",
              "status": "completed_today",
              "detail": "PHQ-9 6; no thoughts of self-harm",
              "observation_ids": [
                "OBS-PHQ9-V3"
              ],
              "guideline_ids": [
                "GL-USPSTF-DEP-2023",
                "GL-CMID-2026"
              ]
            }
          ],
          "follow_up": "Radiotherapy with temozolomide from Monday for six weeks, with weekly blood counts at the radiation clinic. Primary care review at the end of radiotherapy. Call for fever, bruising, a seizure, new weakness or headache",
          "guideline_ids": [
            "GL-NCCN-CNS-2026",
            "GL-EANO-GLIOMA-2021",
            "GL-WHO-CNS5-2021",
            "GL-ASCO-SNO-2022",
            "GL-STUPP-2005",
            "GL-HEGI-2005",
            "GL-TMZ-LABEL",
            "GL-RANO-2023",
            "GL-SNO-EANO-AED-2021",
            "GL-ASCO-VTE-2023",
            "GL-EFNS-PPS-2006",
            "GL-USPSTF-DEP-2023",
            "GL-CMID-2026"
          ]
        }
      },
      {
        "id": "ENC-004",
        "display": "End of six weeks of radiotherapy with daily temozolomide: blood counts, liver tests, Pneumocystis prophylaxis, fatigue, mood, tumor-treating fields and an early palliative care referral",
        "status": "finished",
        "date": "2026-09-14",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-04"
        },
        "documentation": {
          "chief_complaint": "Review at the end of six weeks of radiotherapy with daily temozolomide",
          "hpi": {
            "narrative": "Ms. Rudolph returns on the first weekday after her last radiotherapy fraction. She completed all 30 fractions and took temozolomide every day without a break, the 42nd and last dose last night. Nausea was mild and controlled by ondansetron before each dose. She stopped dexamethasone a month ago and her fingerstick glucose readings came back below 120 mg/dL, so she stopped checking. She is more tired each week, sleeps after lunch and has worked only a few hours a day for the past two weeks. Her hair has fallen out over the treated area and the skin there is pink. She has had no headache, seizure, change in speech, weakness, fever, bruising, cough or fall. The weekly blood counts at the radiation clinic were normal in the first five weeks; the week 6 count was not drawn. She has read about tumor-treating fields and wants to talk about them. She has had no thoughts of self-harm.",
            "elements": [
              {
                "label": "Treatment",
                "value": "Radiotherapy 60 Gy in 30 fractions and 42 days of temozolomide completed on schedule"
              },
              {
                "label": "Steroid",
                "value": "Off dexamethasone for a month; glucose normal"
              },
              {
                "label": "Symptoms",
                "value": "Fatigue, mild nausea, hair loss and pink skin over the field"
              },
              {
                "label": "Blood counts",
                "value": "Normal for five weeks; week 6 not drawn"
              },
              {
                "label": "Her question",
                "value": "Whether to use tumor-treating fields"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "positive",
              "finding": "Fatigue, worse each week; no fever; weight down 2.2 kg since the steroid stopped"
            },
            {
              "system": "Gastrointestinal",
              "status": "positive",
              "finding": "Mild nausea after the doses, controlled; no vomiting; no constipation"
            },
            {
              "system": "Integumentary",
              "status": "positive",
              "finding": "Hair loss over the treated area; pink scalp without blisters"
            },
            {
              "system": "Neurological",
              "status": "negative",
              "finding": "No headache, seizure, speech change or new weakness"
            },
            {
              "system": "Hematologic and lymphatic",
              "status": "negative",
              "finding": "No bruising, nosebleeds or gum bleeding"
            },
            {
              "system": "Respiratory",
              "status": "negative",
              "finding": "No cough or breathlessness"
            },
            {
              "system": "Psychiatric",
              "status": "positive",
              "finding": "Low in energy and sometimes discouraged; PHQ-9 8, mostly from tiredness and sleep; no thoughts of self-harm"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Tired but well; weight 67.2 kg; blood pressure 118/74, pulse 80, temperature 36.8 °C"
            },
            {
              "system": "Head",
              "finding": "Alopecia over the left frontal field; grade 1 radiation dermatitis; incision healed"
            },
            {
              "system": "Mouth",
              "finding": "No ulcers or thrush"
            },
            {
              "system": "Skin",
              "finding": "No bruising or petechiae"
            },
            {
              "system": "Neurological",
              "finding": "Speech fluent; strength full in all four limbs; finger tapping equal; gait steady"
            },
            {
              "system": "Extremities",
              "finding": "No leg swelling or calf tenderness"
            },
            {
              "system": "Psychiatric",
              "finding": "Tired, warm and engaged"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-003",
              "display": "Glioblastoma, IDH-wildtype, MGMT methylated, after chemoradiation",
              "assessment": "Chemoradiation completed on schedule. Platelets 112 (grade 1) and white cells 3.6 with neutrophils 2.4 are expected at the end of daily temozolomide and will recover during the four-week break. ALT 48 and AST 39 U/L are a grade 1 rise, common with temozolomide; to be rechecked before adjuvant treatment. Fatigue at this point is mainly from radiotherapy and should ease over the coming weeks. We discussed tumor-treating fields: in the EF-14 trial, adding them to adjuvant temozolomide lengthened survival, at the cost of wearing scalp arrays at least 18 hours a day and possible skin irritation. She chose to start them with adjuvant temozolomide",
              "plan": [
                "Four-week break from temozolomide",
                "MRI of the brain with contrast in about three weeks",
                "Adjuvant temozolomide 150 mg/m2 on days 1 to 5, cycle 1 after the MRI, if neutrophils are at least 1.5 and platelets at least 100",
                "Tumor-treating fields device fitting arranged to start with cycle 1",
                "Palliative care referral now, alongside treatment"
              ]
            },
            {
              "problem_id": "PRB-007",
              "display": "Lymphopenia from temozolomide, grade 2",
              "assessment": "Absolute lymphocytes 0.5: the label calls for Pneumocystis prophylaxis to continue until lymphopenia recovers to grade 1 or better",
              "plan": [
                "Continue sulfamethoxazole-trimethoprim three times a week",
                "Lymphocytes with each blood count"
              ]
            },
            {
              "problem_id": "PRB-006",
              "display": "Steroid-induced hyperglycemia",
              "assessment": "Glucose 96 mg/dL a month after the last dexamethasone dose; resolved",
              "plan": [
                "Problem resolved; recheck glucose if steroids are needed again"
              ]
            },
            {
              "problem_id": "PRB-004",
              "display": "Late effects of childhood poliomyelitis",
              "assessment": "No fall; legs strong; fatigue is explained by treatment rather than a new post-polio pattern, since there is no new weakness, muscle pain or intolerance of cold in the left leg",
              "plan": [
                "Continue home exercises at a gentler level; rest breaks"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "laboratory",
              "measure": "Blood count with neutrophils, lymphocytes and platelets",
              "cadence": "Weekly during concurrent temozolomide",
              "status": "completed_today",
              "detail": "Hemoglobin 11.9 g/dL, white cells 3.6, neutrophils 2.4, lymphocytes 0.5, platelets 112: grade 1 thrombocytopenia and grade 2 lymphopenia",
              "observation_ids": [
                "OBS-HGB-V4",
                "OBS-WBC-V4",
                "OBS-ANC-V4",
                "OBS-LYMPH-V4",
                "OBS-PLT-V4"
              ],
              "guideline_ids": [
                "GL-STUPP-2005",
                "GL-TMZ-LABEL",
                "GL-NCCN-CNS-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Blood count in week 6 of concurrent treatment",
              "cadence": "Weekly during concurrent temozolomide",
              "status": "deferred",
              "detail": "A deviation: not drawn in the last week of radiotherapy because the clinic's standing order was set for the Monday, a holiday that week, and was not moved. No harm resulted: today's count, a week later, shows platelets 112 and neutrophils 2.4, above the levels that would have stopped temozolomide, and she had no bleeding or fever. Corrective action: today's count; future standing orders are tied to treatment days, not a weekday",
              "guideline_ids": [
                "GL-TMZ-LABEL"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Liver tests (ALT, AST, bilirubin)",
              "cadence": "Baseline, during treatment, before each cycle, and two to four weeks after the last dose",
              "status": "completed_today",
              "detail": "ALT 48, AST 39 U/L (grade 1), bilirubin 0.6 mg/dL; recheck before cycle 1",
              "observation_ids": [
                "OBS-ALT-V4",
                "OBS-AST-V4",
                "OBS-TBIL-V4"
              ],
              "guideline_ids": [
                "GL-TMZ-LABEL"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Kidney function and glucose",
              "cadence": "Each visit; glucose after a steroid course",
              "status": "completed_today",
              "detail": "Creatinine 0.80 mg/dL, eGFR 88; glucose 96 mg/dL off dexamethasone",
              "observation_ids": [
                "OBS-CR-V4",
                "OBS-EGFR-V4",
                "OBS-GLU-V4"
              ],
              "guideline_ids": [
                "GL-EANO-GLIOMA-2021",
                "GL-NCCN-CNS-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Hepatitis B, hepatitis C and HIV screening",
              "cadence": "Before chemotherapy",
              "status": "up_to_date",
              "detail": "All negative",
              "guideline_ids": [
                "GL-NCCN-CNS-2026",
                "GL-EANO-GLIOMA-2021"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Pneumocystis pneumonia prophylaxis",
              "cadence": "During concurrent temozolomide, and until lymphopenia is grade 1 or better",
              "status": "completed_today",
              "detail": "Taken as prescribed without rash; continues for grade 2 lymphopenia",
              "guideline_ids": [
                "GL-TMZ-LABEL"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Antiemetic before temozolomide",
              "cadence": "Each dose",
              "status": "completed_today",
              "detail": "Ondansetron effective; no vomiting",
              "guideline_ids": [
                "GL-TMZ-LABEL"
              ]
            },
            {
              "domain": "imaging",
              "measure": "MRI of the brain after chemoradiation",
              "cadence": "About four weeks after radiotherapy, as the new baseline",
              "status": "ordered",
              "detail": "In about three weeks; enhancement in the first three months may be treatment effect (pseudoprogression) and is read by RANO 2.0",
              "guideline_ids": [
                "GL-RANO-2023",
                "GL-NCCN-CNS-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Neurologic examination (language, strength, gait)",
              "cadence": "Each visit",
              "status": "completed_today",
              "detail": "No deficit; speech fluent; strength full",
              "guideline_ids": [
                "GL-NCCN-CNS-2026",
                "GL-EANO-GLIOMA-2021"
              ]
            },
            {
              "domain": "examination",
              "measure": "Radiation skin reaction and hair loss",
              "cadence": "Weekly during radiotherapy and at the end",
              "status": "completed_today",
              "detail": "Grade 1 dermatitis; alopecia over the field",
              "guideline_ids": [
                "GL-NCCN-CNS-2026",
                "GL-EANO-GLIOMA-2021"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Seizure history and antiseizure drug need",
              "cadence": "Each visit",
              "status": "not_indicated",
              "detail": "No seizure; no antiseizure drug",
              "guideline_ids": [
                "GL-SNO-EANO-AED-2021"
              ]
            },
            {
              "domain": "examination",
              "measure": "Signs of leg clot or pulmonary embolism",
              "cadence": "Each visit",
              "status": "completed_today",
              "detail": "None",
              "guideline_ids": [
                "GL-ASCO-VTE-2023"
              ]
            },
            {
              "domain": "survey",
              "measure": "Performance status (Karnofsky)",
              "cadence": "Each visit",
              "status": "completed_today",
              "detail": "Karnofsky 80, from fatigue",
              "observation_ids": [
                "OBS-KPS-V4"
              ],
              "guideline_ids": [
                "GL-NCCN-CNS-2026",
                "GL-EANO-GLIOMA-2021"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Tumor-treating fields",
              "cadence": "Offered with adjuvant temozolomide for supratentorial glioblastoma",
              "status": "completed_today",
              "detail": "Benefits, daily wear and skin effects discussed; she chose to start them with cycle 1",
              "guideline_ids": [
                "GL-EF14-2017",
                "GL-NCCN-CNS-2026",
                "GL-EANO-GLIOMA-2021"
              ]
            },
            {
              "domain": "referral",
              "measure": "Palliative care",
              "cadence": "Early, alongside cancer treatment, for a serious illness with a high symptom burden",
              "status": "referred",
              "detail": "Outpatient consultation booked in two weeks",
              "guideline_ids": [
                "GL-ASCO-PALL-2024",
                "GL-EANO-GLIOMA-2021"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Falls, leg strength and late effects of polio",
              "cadence": "Each visit",
              "status": "completed_today",
              "detail": "No falls; home exercises at a gentler level; cane on uneven ground",
              "guideline_ids": [
                "GL-EFNS-PPS-2006"
              ]
            },
            {
              "domain": "survey",
              "measure": "Distress and depression screen (PHQ-9)",
              "cadence": "At diagnosis, each treatment phase, and when symptoms change",
              "status": "completed_today",
              "detail": "PHQ-9 8, mostly from fatigue and sleep; no thoughts of self-harm",
              "observation_ids": [
                "OBS-PHQ9-V4"
              ],
              "guideline_ids": [
                "GL-USPSTF-DEP-2023",
                "GL-CMID-2026"
              ]
            }
          ],
          "follow_up": "MRI in about three weeks; palliative care in two weeks. Review with the MRI result on the day adjuvant temozolomide starts. Call for fever, bruising, bleeding, a seizure, headache or new weakness",
          "guideline_ids": [
            "GL-NCCN-CNS-2026",
            "GL-EANO-GLIOMA-2021",
            "GL-STUPP-2005",
            "GL-TMZ-LABEL",
            "GL-EF14-2017",
            "GL-RANO-2023",
            "GL-ASCO-PALL-2024",
            "GL-SNO-EANO-AED-2021",
            "GL-ASCO-VTE-2023",
            "GL-EFNS-PPS-2006",
            "GL-USPSTF-DEP-2023",
            "GL-CMID-2026"
          ]
        }
      },
      {
        "id": "ENC-005",
        "display": "Post-chemoradiation MRI result, day 1 of adjuvant temozolomide, the start of tumor-treating fields, and the palliative care plan",
        "status": "finished",
        "date": "2026-10-09",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-04"
        },
        "documentation": {
          "chief_complaint": "MRI result after chemoradiation and the first day of adjuvant temozolomide",
          "hpi": {
            "narrative": "Ms. Rudolph returns four weeks after the end of radiotherapy. The MRI two days ago shows thin, smooth enhancement along the edge of the resection cavity and no new or nodular enhancement, with less swelling than after surgery. Her energy has improved over the past two weeks and she is working half days. The scalp has healed. She saw the palliative care team eleven days ago, talked through her symptoms, her understanding of the illness and what matters most to her, and completed an advance directive naming a health care agent. The tumor-treating fields device was fitted yesterday and she wore it overnight. She has had no headache, seizure, change in speech, weakness or fall. She has had no thoughts of self-harm.",
            "elements": [
              {
                "label": "MRI",
                "value": "Treatment-related change only; no progression (RANO 2.0)"
              },
              {
                "label": "Energy",
                "value": "Improving; half days at work"
              },
              {
                "label": "Palliative care",
                "value": "Seen eleven days ago; advance directive completed"
              },
              {
                "label": "Today",
                "value": "Adjuvant temozolomide cycle 1, day 1; tumor-treating fields started"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "positive",
              "finding": "Tired in the afternoons, less than before; no fever"
            },
            {
              "system": "Gastrointestinal",
              "status": "negative",
              "finding": "No nausea, vomiting or constipation"
            },
            {
              "system": "Integumentary",
              "status": "negative",
              "finding": "Scalp healed; no redness under the new arrays this morning"
            },
            {
              "system": "Neurological",
              "status": "negative",
              "finding": "No headache, seizure, speech change or weakness"
            },
            {
              "system": "Hematologic and lymphatic",
              "status": "negative",
              "finding": "No bruising or bleeding"
            },
            {
              "system": "Respiratory",
              "status": "negative",
              "finding": "No cough or breathlessness"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "More hopeful; PHQ-9 6; no thoughts of self-harm"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well; weight 66.6 kg; blood pressure 120/76, pulse 74"
            },
            {
              "system": "Head",
              "finding": "Scalp shaved for the arrays; skin intact; radiation dermatitis resolved"
            },
            {
              "system": "Neurological",
              "finding": "Speech fluent; strength full in all four limbs; gait steady"
            },
            {
              "system": "Extremities",
              "finding": "No leg swelling or calf tenderness"
            },
            {
              "system": "Psychiatric",
              "finding": "Engaged and composed"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-003",
              "display": "Glioblastoma, IDH-wildtype, MGMT methylated, starting adjuvant temozolomide with tumor-treating fields",
              "assessment": "The first MRI after chemoradiation shows treatment-related change without progression by RANO 2.0 and becomes the new baseline; any new enhancement in the next few months would be weighed against pseudoprogression before changing treatment. Neutrophils 2.9 and platelets 168 allow cycle 1, and ALT 31 and AST 27 U/L are back in range. Cycle 1 of temozolomide at 150 mg/m2 (280 mg) on days 1 to 5 starts tonight. Tumor-treating fields started yesterday, at least 18 hours a day",
              "plan": [
                "Temozolomide 280 mg at bedtime on days 1 to 5, with ondansetron first",
                "Blood count on day 22; escalate to 200 mg/m2 for cycle 2 if counts and tolerance allow",
                "Tumor-treating fields at least 18 hours a day; scalp checks at each array change",
                "MRI every two to three months during adjuvant treatment"
              ]
            },
            {
              "problem_id": "PRB-005",
              "display": "Vasogenic cerebral edema",
              "assessment": "Resolved on MRI, off steroids for two months",
              "plan": [
                "Problem resolved"
              ]
            },
            {
              "problem_id": "PRB-007",
              "display": "Lymphopenia from temozolomide, grade 2",
              "assessment": "Absolute lymphocytes 0.6; still grade 2",
              "plan": [
                "Continue sulfamethoxazole-trimethoprim three times a week"
              ]
            },
            {
              "problem_id": "PRB-004",
              "display": "Late effects of childhood poliomyelitis",
              "assessment": "No falls; legs strong; walking daily",
              "plan": [
                "Continue home exercises"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "imaging",
              "measure": "MRI of the brain after chemoradiation (RANO 2.0)",
              "cadence": "About four weeks after radiotherapy, then every two to three months",
              "status": "up_to_date",
              "detail": "Two days ago: treatment-related change, no progression; new baseline",
              "guideline_ids": [
                "GL-RANO-2023",
                "GL-NCCN-CNS-2026"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Next MRI of the brain",
              "cadence": "Every two to three months during adjuvant treatment",
              "status": "due",
              "detail": "After cycle 2",
              "guideline_ids": [
                "GL-RANO-2023",
                "GL-NCCN-CNS-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Blood count with neutrophils, lymphocytes and platelets",
              "cadence": "Before each adjuvant cycle and on day 22",
              "status": "completed_today",
              "detail": "Hemoglobin 12.2 g/dL, white cells 4.4, neutrophils 2.9, lymphocytes 0.6, platelets 168: cycle 1 can start",
              "observation_ids": [
                "OBS-HGB-V5",
                "OBS-WBC-V5",
                "OBS-ANC-V5",
                "OBS-LYMPH-V5",
                "OBS-PLT-V5"
              ],
              "guideline_ids": [
                "GL-STUPP-2005",
                "GL-TMZ-LABEL",
                "GL-NCCN-CNS-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Day-22 blood count",
              "cadence": "Day 22 of each adjuvant cycle, then weekly until neutrophils exceed 1.5",
              "status": "due",
              "detail": "Booked for the preventive visit three weeks from now",
              "guideline_ids": [
                "GL-TMZ-LABEL"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Liver tests (ALT, AST, bilirubin)",
              "cadence": "Before each cycle and midway through cycle 1",
              "status": "completed_today",
              "detail": "ALT 31, AST 27 U/L, bilirubin 0.5 mg/dL; the grade 1 rise has resolved",
              "observation_ids": [
                "OBS-ALT-V5",
                "OBS-AST-V5",
                "OBS-TBIL-V5"
              ],
              "guideline_ids": [
                "GL-TMZ-LABEL"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Liver tests midway through adjuvant cycle 1",
              "cadence": "Midway through the first cycle",
              "status": "deferred",
              "detail": "A planned deviation: to spare her an extra trip, the mid-cycle liver tests will be drawn with the day-22 blood count, about a week after the label's midpoint. Today's liver tests are normal after a grade 1 rise. Outcome and action to be recorded at that draw",
              "guideline_ids": [
                "GL-TMZ-LABEL"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Kidney function and glucose",
              "cadence": "Each visit",
              "status": "completed_today",
              "detail": "Creatinine 0.81 mg/dL, eGFR 86; glucose 91 mg/dL",
              "observation_ids": [
                "OBS-CR-V5",
                "OBS-EGFR-V5",
                "OBS-GLU-V5"
              ],
              "guideline_ids": [
                "GL-NCCN-CNS-2026",
                "GL-EANO-GLIOMA-2021"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Pneumocystis pneumonia prophylaxis",
              "cadence": "Until lymphopenia is grade 1 or better",
              "status": "completed_today",
              "detail": "Continues for lymphocytes 0.6",
              "guideline_ids": [
                "GL-TMZ-LABEL"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Antiemetic before temozolomide",
              "cadence": "Each dose",
              "status": "completed_today",
              "detail": "Ondansetron before each bedtime dose",
              "guideline_ids": [
                "GL-TMZ-LABEL"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Tumor-treating fields: wear time and scalp care",
              "cadence": "Each visit while in use",
              "status": "completed_today",
              "detail": "Started yesterday; at least 18 hours a day; shave and shift arrays at each change; report redness or blisters",
              "guideline_ids": [
                "GL-EF14-2017",
                "GL-NCCN-CNS-2026",
                "GL-EANO-GLIOMA-2021"
              ]
            },
            {
              "domain": "examination",
              "measure": "Neurologic examination (language, strength, gait)",
              "cadence": "Each visit",
              "status": "completed_today",
              "detail": "No deficit",
              "guideline_ids": [
                "GL-NCCN-CNS-2026",
                "GL-EANO-GLIOMA-2021"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Seizure history and antiseizure drug need",
              "cadence": "Each visit",
              "status": "not_indicated",
              "detail": "No seizure; no antiseizure drug",
              "guideline_ids": [
                "GL-SNO-EANO-AED-2021"
              ]
            },
            {
              "domain": "examination",
              "measure": "Signs of leg clot or pulmonary embolism",
              "cadence": "Each visit",
              "status": "completed_today",
              "detail": "None",
              "guideline_ids": [
                "GL-ASCO-VTE-2023"
              ]
            },
            {
              "domain": "survey",
              "measure": "Performance status (Karnofsky)",
              "cadence": "Each visit",
              "status": "completed_today",
              "detail": "Karnofsky 80",
              "observation_ids": [
                "OBS-KPS-V5"
              ],
              "guideline_ids": [
                "GL-NCCN-CNS-2026",
                "GL-EANO-GLIOMA-2021"
              ]
            },
            {
              "domain": "referral",
              "measure": "Palliative care",
              "cadence": "Early and ongoing",
              "status": "up_to_date",
              "detail": "Seen eleven days ago; advance directive completed; follow-up in two months",
              "guideline_ids": [
                "GL-ASCO-PALL-2024",
                "GL-EANO-GLIOMA-2021"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Falls, leg strength and late effects of polio",
              "cadence": "Each visit",
              "status": "completed_today",
              "detail": "No falls; legs strong; walking daily",
              "guideline_ids": [
                "GL-EFNS-PPS-2006"
              ]
            },
            {
              "domain": "survey",
              "measure": "Distress and depression screen (PHQ-9)",
              "cadence": "At diagnosis, each treatment phase, and when symptoms change",
              "status": "completed_today",
              "detail": "PHQ-9 6; no thoughts of self-harm",
              "observation_ids": [
                "OBS-PHQ9-V5"
              ],
              "guideline_ids": [
                "GL-USPSTF-DEP-2023",
                "GL-CMID-2026"
              ]
            }
          ],
          "follow_up": "Temozolomide days 1 to 5 from tonight. Preventive visit and day-22 blood count with liver tests in three weeks. Neuro-oncology review and MRI after cycle 2. Call for fever, bruising, a seizure, headache, new weakness or scalp blisters",
          "guideline_ids": [
            "GL-NCCN-CNS-2026",
            "GL-EANO-GLIOMA-2021",
            "GL-STUPP-2005",
            "GL-TMZ-LABEL",
            "GL-EF14-2017",
            "GL-RANO-2023",
            "GL-ASCO-PALL-2024",
            "GL-SNO-EANO-AED-2021",
            "GL-ASCO-VTE-2023",
            "GL-EFNS-PPS-2006",
            "GL-USPSTF-DEP-2023",
            "GL-CMID-2026"
          ]
        }
      },
      {
        "id": "ENC-006",
        "display": "Periodic adult preventive visit",
        "status": "finished",
        "date": "2026-10-29",
        "visit_type": "preventive_adult",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "86013001",
          "display": "Periodic reevaluation and management of healthy individual",
          "validation_status": "validated",
          "validated_on": "2026-11-04"
        },
        "documentation": {
          "chief_complaint": "Periodic adult preventive visit",
          "billing_note": "CPT 99396 (periodic preventive medicine, established patient, age 40 to 64) with CPT 99497 (advance care planning), both on the same day",
          "health_risk_assessment_method": "Completed by the patient on the clinic's paper form in the waiting room and reviewed with her by Dr. Haynes-Whitaker",
          "hpi": {
            "narrative": "Ms. Rudolph is a 54-year-old hospital executive and former Olympic sprinter with an IDH-wildtype, MGMT-methylated glioblastoma of the left frontal lobe, treated with gross total resection and six weeks of radiotherapy with daily temozolomide, who comes for her yearly preventive visit on day 21 of her first adjuvant temozolomide cycle. The MRI three weeks ago showed no progression. She took the five doses of temozolomide without vomiting, using ondansetron before each. She wears the tumor-treating fields device about 19 hours a day; the scalp under the arrays is a little pink but not broken. She is tired by mid-afternoon but works mornings from home. She has had no headache, seizure, change in speech, weakness or fall. Her right hand is back to normal for writing. She walks most days with the cane she keeps for uneven ground.",
            "elements": [
              {
                "label": "Visit",
                "value": "Periodic adult preventive visit, age 54"
              },
              {
                "label": "Glioblastoma",
                "value": "No progression on the post-chemoradiation MRI; adjuvant cycle 1, day 21"
              },
              {
                "label": "Tumor-treating fields",
                "value": "About 19 hours a day; mild scalp redness"
              },
              {
                "label": "Mood",
                "value": "PHQ-2 1"
              }
            ]
          },
          "health_risk_assessment": [
            {
              "domain": "Self-rated health",
              "finding": "Fair; tired in the afternoons"
            },
            {
              "domain": "Psychosocial",
              "finding": "Close to her family and friends; still working part days; keeps her spirits up with time with her family and her foundation's young athletes"
            },
            {
              "domain": "Substance use",
              "finding": "No tobacco; no alcohol since surgery; no drug use"
            },
            {
              "domain": "Physical activity",
              "finding": "Walks 20 to 30 minutes most days; home exercises from physical therapy three times a week"
            },
            {
              "domain": "Nutrition",
              "finding": "Appetite fair; eats small meals; weight steady"
            },
            {
              "domain": "Sleep",
              "finding": "Seven to eight hours with the device on; a short nap after lunch"
            },
            {
              "domain": "Falls and home safety",
              "finding": "No falls; grab bars and night lights in place; cane for uneven ground"
            },
            {
              "domain": "Driving",
              "finding": "Not driving since the first symptoms; family and friends drive her"
            },
            {
              "domain": "Activities of daily living",
              "finding": "Independent in all"
            },
            {
              "domain": "Seat belt and smoke alarms",
              "finding": "Always wears a seat belt; smoke alarms tested"
            }
          ],
          "ros": [
            {
              "system": "Constitutional",
              "status": "positive",
              "finding": "Afternoon fatigue; no fever or weight loss"
            },
            {
              "system": "Eyes",
              "status": "negative",
              "finding": "No double or blurred vision"
            },
            {
              "system": "Ears, nose, mouth, and throat",
              "status": "negative",
              "finding": "No mouth sores or sore throat"
            },
            {
              "system": "Cardiovascular",
              "status": "negative",
              "finding": "No chest pain or leg swelling"
            },
            {
              "system": "Respiratory",
              "status": "negative",
              "finding": "No cough or breathlessness"
            },
            {
              "system": "Gastrointestinal",
              "status": "negative",
              "finding": "No nausea now, vomiting, diarrhea or constipation"
            },
            {
              "system": "Genitourinary",
              "status": "negative",
              "finding": "No urinary symptoms; no vaginal bleeding"
            },
            {
              "system": "Breast",
              "status": "negative",
              "finding": "No lump or nipple change"
            },
            {
              "system": "Musculoskeletal",
              "status": "negative",
              "finding": "No new weakness, muscle pain or joint pain in either leg"
            },
            {
              "system": "Integumentary",
              "status": "positive",
              "finding": "Mild pinkness of the scalp under the device arrays; no blisters or broken skin"
            },
            {
              "system": "Neurological",
              "status": "negative",
              "finding": "No headache, seizure, numbness or speech change"
            },
            {
              "system": "Hematologic and lymphatic",
              "status": "negative",
              "finding": "No bruising or bleeding"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Mood steady; PHQ-2 1"
            }
          ],
          "exam": [
            {
              "system": "Constitutional",
              "finding": "Well; weight 66.9 kg; blood pressure 118/72; pulse 76; temperature 36.5 °C"
            },
            {
              "system": "Head",
              "finding": "Craniotomy incision healed; hair loss over the radiation field; scalp under the arrays mildly pink, intact"
            },
            {
              "system": "Mouth",
              "finding": "No ulcers or thrush"
            },
            {
              "system": "Breasts",
              "finding": "Clinical breast examination with a chaperone, at her choice: no masses, skin or nipple changes, or axillary nodes"
            },
            {
              "system": "Cardiovascular",
              "finding": "Regular rhythm; no murmur"
            },
            {
              "system": "Respiratory",
              "finding": "Clear"
            },
            {
              "system": "Abdomen",
              "finding": "Soft, non-tender"
            },
            {
              "system": "Extremities",
              "finding": "No leg swelling; calves soft and non-tender; left calf slightly smaller than the right, as before"
            },
            {
              "system": "Skin",
              "finding": "No bruising or petechiae"
            },
            {
              "system": "Neurological",
              "finding": "Fluent speech; strength full in all four limbs; steady gait; Timed Up and Go 9 seconds"
            },
            {
              "system": "Psychiatric",
              "finding": "Warm, engaged and direct"
            }
          ],
          "assessment_plan": [
            {
              "display": "Periodic adult preventive visit completed",
              "assessment": "Health risk assessment reviewed and the prevention plan updated. Her screening for breast, cervical and colorectal cancer is up to date, and we agreed to decide about the next rounds of screening together when they fall due, in light of her treatment. Influenza, PCV20 and the first recombinant zoster dose given today: inactivated vaccines are safe during temozolomide, though her response may be blunted. A COVID-19 vaccine this season is due at her pharmacy. She declined lipid screening for now while she is on treatment",
              "plan": [
                "Second zoster dose in one to two months",
                "COVID-19 vaccine this season",
                "Dental and eye examinations this year",
                "Next preventive visit in one year"
              ]
            },
            {
              "problem_id": "PRB-003",
              "display": "Glioblastoma, IDH-wildtype, CNS WHO grade 4, MGMT methylated, on adjuvant temozolomide and tumor-treating fields",
              "assessment": "Day-21 blood count: neutrophils 1.9 and platelets 121, both above the thresholds for the next cycle, so cycle 2 can start on day 29, and the dose can rise to 200 mg/m2 as the label allows when the cycle 1 nadir and tolerance are this good. ALT 33 and AST 29 U/L: the cycle 1 liver tests, drawn today with the count rather than at the midpoint of the cycle, are normal (the deviation is recorded in the cycle 1 note). Scalp redness under the arrays is grade 1",
              "plan": [
                "Cycle 2 of temozolomide at 200 mg/m2 on day 29 if counts are still adequate",
                "Topical corticosteroid cream for the scalp between array changes; shift the arrays slightly at each change",
                "Blood count weekly until counts recover, then on day 22 of each cycle"
              ]
            },
            {
              "problem_id": "PRB-007",
              "display": "Lymphopenia from temozolomide, grade 2",
              "assessment": "Absolute lymphocytes 0.6; Pneumocystis prophylaxis continues",
              "plan": [
                "Continue sulfamethoxazole-trimethoprim three times a week"
              ]
            },
            {
              "problem_id": "PRB-004",
              "display": "Late effects of childhood poliomyelitis",
              "assessment": "No new weakness, fatigue beyond what treatment explains, or pain in the legs to suggest post-polio syndrome; walking safely",
              "plan": [
                "Home exercises; check leg strength at each visit"
              ]
            }
          ],
          "prevention_plan": [
            {
              "service": "Blood pressure screening",
              "status": "completed_today",
              "detail": "118/72 mmHg",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Depression screening",
              "status": "completed_today",
              "detail": "PHQ-2 score 1; PHQ-9 6 three weeks ago",
              "guideline_ids": [
                "GL-USPSTF-DEP-2023",
                "GL-CMID-2026"
              ]
            },
            {
              "service": "Unhealthy alcohol use screening",
              "status": "completed_today",
              "detail": "No alcohol since surgery",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Tobacco use",
              "status": "completed_today",
              "detail": "Never",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Breast cancer screening",
              "status": "up_to_date",
              "detail": "Mammogram every two years from 40 to 74; last screening mammogram about a year ago, normal; next to be decided with her when due",
              "guideline_ids": [
                "GL-USPSTF-BRCA-2024"
              ]
            },
            {
              "service": "Cervical cancer screening",
              "status": "up_to_date",
              "detail": "Cytology with HPV testing about two years ago, negative; next due in about three years",
              "guideline_ids": [
                "GL-USPSTF-CERV-2018"
              ]
            },
            {
              "service": "Colorectal cancer screening",
              "status": "up_to_date",
              "detail": "Colonoscopy at 50, normal; next due at 60",
              "guideline_ids": [
                "GL-USPSTF-CRC-2021"
              ]
            },
            {
              "service": "Diabetes screening",
              "status": "up_to_date",
              "detail": "A1c 5.6% before steroids; glucose 91 mg/dL three weeks ago, off steroids",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Lipid screening",
              "status": "declined",
              "detail": "Declined for now: not drawn today, by her choice, while she is on cancer treatment; to be revisited at the next preventive visit",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "HIV, hepatitis B and hepatitis C screening",
              "status": "up_to_date",
              "detail": "All negative before temozolomide",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Osteoporosis screening",
              "status": "not_indicated",
              "detail": "Postmenopausal at 54; dexamethasone for under two months and no fracture, so her estimated fracture risk is below the threshold for bone density testing; to be reconsidered if steroids are needed again or she falls",
              "guideline_ids": [
                "GL-USPSTF-OSTEO-2025"
              ]
            },
            {
              "service": "Fall risk and mobility",
              "status": "completed_today",
              "detail": "No falls; Timed Up and Go 9 seconds; home exercises and home safety measures in place",
              "guideline_ids": [
                "GL-PREV-2026",
                "GL-EFNS-PPS-2006"
              ]
            },
            {
              "service": "Lung cancer screening",
              "status": "not_indicated",
              "detail": "Never smoker",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Influenza, pneumococcal and zoster vaccines",
              "status": "completed_today",
              "detail": "Inactivated influenza vaccine, PCV20 and recombinant zoster dose 1 given today; no live vaccines during chemotherapy",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "COVID-19 vaccine, this season",
              "status": "due",
              "detail": "At her pharmacy, at least a few days apart from the next temozolomide cycle if she prefers",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Dental and eye examinations",
              "status": "due",
              "detail": "Dental review and an eye examination advised this year",
              "guideline_ids": [
                "GL-PREV-2026"
              ]
            }
          ],
          "advance_care_planning": "Voluntary advance care planning discussion of about 20 minutes, with her consent, reviewing the advance directive she completed with the palliative care team last month. She wants treatment aimed at controlling the tumor for as long as it lets her live in a way she values, being at home and with the people she loves, and wants to be told plainly when that balance changes. Her named health care agent is recorded in the confidential part of the chart and is not named here. She asked that information about her health go only to the people she names. To be revisited at each MRI and if her illness changes.",
          "follow_up": "Cycle 2 of temozolomide on day 29 with a blood count first. Neuro-oncology review and MRI after cycle 2. Second zoster dose in one to two months; COVID-19 vaccine this season. Next preventive visit in one year",
          "guideline_ids": [
            "GL-PREV-2026",
            "GL-USPSTF-AB",
            "GL-USPSTF-BRCA-2024",
            "GL-USPSTF-CERV-2018",
            "GL-USPSTF-CRC-2021",
            "GL-USPSTF-OSTEO-2025",
            "GL-CDC-IMZ-2026",
            "GL-TMZ-LABEL",
            "GL-NCCN-CNS-2026"
          ]
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic periodic preventive visit.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:30:00-05:00"
        }
      }
    ],
    "vital_sign_sets": [
      {
        "id": "VSET-001",
        "date": "2026-06-29",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 180,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 68.0,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 21.0,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 126,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 78,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 72,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.7,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 99,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs; no measurement from her life is used.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "VSET-002",
        "date": "2026-07-02",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 180,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 67.8,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 20.9,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 134,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 82,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 78,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 99,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs; no measurement from her life is used.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "VSET-003",
        "date": "2026-07-29",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 180,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 69.4,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 21.4,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 132,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 80,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 76,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs; no measurement from her life is used.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "VSET-004",
        "date": "2026-09-14",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 180,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 67.2,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 20.7,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 118,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 74,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 80,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.8,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs; no measurement from her life is used.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "VSET-005",
        "date": "2026-10-09",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 180,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 66.6,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 20.6,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 120,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 76,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 74,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 99,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs; no measurement from her life is used.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "VSET-006",
        "date": "2026-10-29",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 180,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 66.9,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 20.6,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 118,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 72,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 76,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.5,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 99,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vital signs at the preventive visit, seated.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:30:00-05:00"
        }
      }
    ],
    "social_history": [
      {
        "id": "SOC-001",
        "display": "Vice president of a Nashville hospital; former Olympic champion sprinter, teacher and coach; runs a foundation that supports young track and field athletes",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic modern work history anchored to her documented career.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "SOC-002",
        "display": "Lives in a suburb of Nashville; four grown children and a very large extended family nearby, and many friends from track and field",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0001"
          ],
          "synthetic_reason": "Synthetic household anchored to the public account of her life; no relative is named or given a role.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "SOC-003",
        "display": "Remembers being told as a child that she would never walk again; wants to be told plainly what is happening and to stay as independent and active as she can",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic preference anchored to her own published account of her childhood.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "SOC-004",
        "display": "Never smoker; alcohol rarely; no drug use",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic substance history for the modern episode; her real use was not researched and is not used.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "SOC-005",
        "display": "Walks for exercise most days; drives herself to work",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic activity and driving history; driving matters for the plan.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "SOC-006",
        "display": "Menstrual history: periods stopped about two years ago; no hormone therapy",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic reproductive history; not a historical assertion.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      }
    ],
    "functional_status": [
      {
        "id": "FUNC-001",
        "display": "Independent and working full time; walks without an aid; finds writing and buttons harder with the right hand for ten days. Examination: slight right pronator drift and right grip 4+/5, with full strength in both legs, a steady gait and no papilledema",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic functional status at presentation.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      }
    ],
    "mental_status": [
      {
        "id": "MSE-001",
        "display": "Alert and oriented; speech fluent with occasional pauses to find words and one or two substituted words; follows complex commands; repetition intact; PHQ-2 negative; no thoughts of self-harm",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic mental-status finding; not a claim about her real mental state.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      }
    ],
    "consultation": {
      "referral": {
        "question": "Three weeks of headaches on waking, with ten days of word-finding pauses and clumsiness of the right hand, in a previously well 54-year-old hospital executive and former Olympic sprinter. Examination today shows mild expressive language difficulty, a slight right pronator drift and right grip weakness. MRI of the brain with and without contrast is booked for tomorrow morning. Please see her within a week, with neurosurgery, to review the MRI with her and plan diagnosis and treatment if it shows a tumor",
        "urgency": "Within one week; the same day if the MRI shows a mass with shift or she worsens",
        "pertinent_history": "Headaches on waking for three weeks, now most mornings, eased by acetaminophen; for ten days, pauses to find words and dropping things from the right hand. No seizure, vomiting, fever, visual change or weight loss. No history of cancer. Childhood poliomyelitis with paralysis of the left leg, treated with a brace for several years; she walked without it by about twelve and became an Olympic sprinter, and has no new weakness or fatigue. Never smoker; alcohol rarely. Examination today: blood pressure 126/78; alert, fluent with occasional word-finding pauses and one or two substituted words; mild flattening of the right nasolabial fold; slight right pronator drift; right grip 4+/5; legs 5/5; gait steady; no papilledema. Results today: hemoglobin 13.1 g/dL, platelets 262, sodium 139, creatinine 0.86 mg/dL, eGFR 80, glucose 92 mg/dL, A1c 5.6%. Karnofsky 80. PHQ-2 negative. Medicines: acetaminophen as needed. No known allergies. Advised not to drive. She wants plain information, and wants to decide who is told",
        "questions": [
          "What does the MRI show, what is the most likely diagnosis, and is any further imaging needed before surgery?",
          "Do you recommend biopsy or resection, and how can her language and right-hand function be protected?",
          "Which pathology and molecular tests are needed for the diagnosis?",
          "If this is a high-grade glioma, what treatment should follow surgery?",
          "How should steroids, seizures and the risk of blood clots be managed, and what should primary care monitor?"
        ]
      },
      "consultant_note": {
        "history": "Ms. Rudolph, 54, is seen with the neurosurgery team at the request of Dr. Haynes-Whitaker, three days after she reported three weeks of morning headaches and ten days of word-finding pauses and right-hand clumsiness. The MRI the next morning showed a left frontal mass, and dexamethasone 4 mg twice a day was started that afternoon; since then her headache has eased and her speech has improved. CT of the chest, abdomen and pelvis yesterday showed no cancer elsewhere. She has had no seizure. She had polio as a small child, which left her left leg paralyzed for some years; she recovered fully and became an Olympic sprinter. She works as a hospital vice president, is right-handed, and wants the facts given plainly",
        "data_reviewed": "Dr. Haynes-Whitaker's intake note. MRI of the brain with and without contrast, with diffusion and perfusion: a 3.8 x 3.2 cm ring-enhancing mass in the left posterior frontal lobe involving the posterior inferior frontal gyrus and abutting the precentral gyrus, with central necrosis, raised relative cerebral blood volume in the rim, no restricted diffusion in the necrotic center, surrounding edema and 5 mm midline shift; no other lesion. CT of the chest, abdomen and pelvis: no primary tumor or other lesion. Today: hemoglobin 13.0 g/dL, white cells 11.8 on dexamethasone, platelets 270; sodium 140, potassium 4.0, creatinine 0.84 mg/dL; glucose 138 mg/dL not fasting; INR 1.0, aPTT 29 seconds",
        "exam": [
          {
            "system": "Mental status and speech",
            "finding": "Alert and oriented; fluent with rare word-finding pauses; naming, repetition and comprehension intact"
          },
          {
            "system": "Cranial nerves",
            "finding": "Mild right nasolabial flattening; no papilledema"
          },
          {
            "system": "Motor",
            "finding": "Slight right pronator drift; right grip and finger extension 4+/5; legs 5/5"
          },
          {
            "system": "Gait",
            "finding": "Steady; tandem gait slightly unsteady"
          }
        ],
        "assessment": [
          {
            "problem_id": "PRB-002",
            "display": "Left posterior frontal ring-enhancing mass, presumed high-grade glioma",
            "assessment": "A single necrotic ring-enhancing mass with raised perfusion in a woman of 54 without cancer elsewhere on CT is most likely a glioblastoma. A solitary metastasis has been made unlikely by the CT; lymphoma would usually enhance solidly and restrict diffusion; an abscess would restrict diffusion in its center. The mass sits just behind the expressive language area and in front of the motor strip, and the edema explains much of her symptoms. Maximal safe resection, rather than biopsy alone, gives the tissue diagnosis, relieves the mass effect and improves survival, and an awake craniotomy with cortical and subcortical language and motor mapping lets the surgeons remove the tumor while protecting speech and hand function. A functional MRI with tractography beforehand will show the language areas and the motor tract. The tissue needs an integrated WHO CNS5 diagnosis: IDH1 R132H immunostaining, with IDH1 and IDH2 sequencing if it is negative because she is 54, ATRX and p53, the TERT promoter, EGFR amplification and chromosome 7 gain with 10 loss, which define glioblastoma when IDH is wild-type, CDKN2A, histone H3 and BRAF, and MGMT promoter methylation, which predicts benefit from temozolomide. If this is a glioblastoma, the standard after surgery is radiotherapy 60 Gy in 30 fractions with daily temozolomide 75 mg/m2, Pneumocystis prophylaxis and weekly blood counts, then six cycles of adjuvant temozolomide, with tumor-treating fields offered for the adjuvant phase, and screening for a clinical trial. Dexamethasone is right for edema causing symptoms and should be tapered as soon as possible after surgery. She has had no seizure, so she should not have a prophylactic antiseizure drug. Brain tumors carry a high risk of venous thromboembolism: she needs mechanical and then heparin prophylaxis in hospital after surgery, but not routinely at home"
          }
        ],
        "recommendations": [
          "Functional MRI with diffusion tensor tractography in four days",
          "Awake left frontal craniotomy with language and motor mapping for maximal safe resection in six days, with an MRI within 48 hours of surgery",
          "Integrated WHO CNS5 diagnosis: IDH1 R132H immunostaining with IDH1 and IDH2 sequencing if negative, ATRX, p53, TERT promoter, EGFR, chromosome 7 and 10, CDKN2A, histone H3, BRAF and MGMT promoter methylation",
          "If glioblastoma: radiotherapy 60 Gy in 30 fractions with temozolomide 75 mg/m2 daily, then six cycles of temozolomide 150 to 200 mg/m2 on days 1 to 5 every 28 days; Pneumocystis prophylaxis during concurrent treatment and while lymphopenia lasts; antiemetic before each dose; tumor-treating fields offered with adjuvant temozolomide; clinical trial screening",
          "Dexamethasone 4 mg twice a day with famotidine until surgery, then a taper to stop within a few weeks; glucose checks while on the steroid",
          "No prophylactic antiseizure drug; levetiracetam if a seizure occurs; seizure first aid for her household",
          "Mechanical and then low-molecular-weight heparin prophylaxis in hospital after surgery; no routine prophylaxis at home; teach the signs of leg clot and pulmonary embolism",
          "For primary care: weekly blood counts during chemoradiation and on day 22 of each adjuvant cycle, liver tests at baseline and before each cycle, MRI four weeks after radiotherapy and then every two to three months read with allowance for pseudoprogression, physical therapy and fall prevention given her new right-sided weakness and old left-leg polio, no driving for now, distress screening, and an early palliative care referral"
        ],
        "communication": "Discussed with Dr. Haynes-Whitaker, who saw her the same day. The MRI and the plan were explained to Ms. Rudolph with the images, and she agreed to the awake craniotomy; she decides who else receives this note",
        "follow_up": "Surgery in six days; review with the integrated diagnosis and the tumor board recommendation before radiotherapy; Dr. Haynes-Whitaker continues primary care and shares the monitoring"
      },
      "guideline_ids": [
        "GL-NCCN-CNS-2026",
        "GL-EANO-GLIOMA-2021",
        "GL-WHO-CNS5-2021",
        "GL-ASCO-SNO-2022",
        "GL-STUPP-2005",
        "GL-HEGI-2005",
        "GL-EF14-2017",
        "GL-TMZ-LABEL",
        "GL-SNO-EANO-AED-2021",
        "GL-ASCO-VTE-2023",
        "GL-ASCO-PALL-2024",
        "GL-RANO-2023"
      ]
    }
  },
  "care_plan": {
    "health_concerns": [
      {
        "id": "HC-001",
        "display": "Headaches on waking for three weeks, now most mornings; words that will not come for ten days; dropping things from the right hand",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic presenting concern; no symptom of her real illness was made public.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "HC-002",
        "display": "She wants the cause found quickly and explained plainly, without being talked around",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic patient-centered concern.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "HC-003",
        "display": "She worries about falling and about losing her independence: her left leg was the weak one when she was a child, and now her right hand is clumsy",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003",
            "CLM-0004",
            "CLM-0005",
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic concern anchored to her documented childhood polio.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      }
    ],
    "goals": [
      {
        "id": "GOAL-001",
        "display": "MRI of the brain within 24 hours and a neuro-oncology and neurosurgery plan within one week of presentation",
        "status": "completed",
        "target_date": "2026-07-02",
        "outcome": "MRI the next morning; consultation three days after the first visit",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic diagnostic-pathway goal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "GOAL-002",
        "display": "Maximal safe resection within two weeks of the MRI, preserving language and right-hand strength",
        "status": "completed",
        "target_date": "2026-07-29",
        "outcome": "Gross total resection of the enhancing tumor nine days after the first visit; speech back to normal within days and right-hand strength nearly normal",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic surgical goal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "GOAL-003",
        "display": "Radiotherapy with daily temozolomide started within six weeks of surgery and completed on schedule",
        "status": "completed",
        "target_date": "2026-09-14",
        "outcome": "Started 26 days after surgery; 30 fractions and 42 days of temozolomide completed without a break",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic treatment goal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "GOAL-004",
        "display": "Dexamethasone tapered off within five weeks of surgery, with glucose back to normal",
        "status": "completed",
        "target_date": "2026-09-14",
        "outcome": "Off dexamethasone five weeks after surgery; glucose 96 mg/dL afterwards",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic steroid goal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "GOAL-005",
        "display": "No falls, and walking independently, through treatment",
        "status": "completed",
        "target_date": "2026-10-09",
        "outcome": "No falls; walks independently, with a cane only on uneven ground; home exercise program continued",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic mobility and safety goal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "GOAL-006",
        "display": "Palliative care involved and her wishes recorded before adjuvant treatment begins",
        "status": "completed",
        "target_date": "2026-10-09",
        "outcome": "Palliative care consultation and advance directive completed eleven days before adjuvant cycle 1",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic goals-of-care goal.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      }
    ],
    "interventions": [
      {
        "id": "INT-001",
        "display": "Urgent neuro-oncology consultation within one week, together with neurosurgery, to review the brain MRI with her and plan diagnosis and treatment if it shows a tumor",
        "status": "completed",
        "guideline_ids": [
          "GL-NCCN-CNS-2026",
          "GL-EANO-GLIOMA-2021"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic specialist consultation booked at intake so that an abnormal MRI reaches a specialist without delay.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "INT-002",
        "display": "New progressive focal neurologic symptoms are imaged promptly: MRI of the brain with and without contrast within 24 hours, with same-day emergency care if she worsens, has a seizure, vomits or becomes drowsy; blood count, chemistry and A1c; no driving until the cause is known",
        "status": "completed",
        "guideline_ids": [
          "GL-NCCN-CNS-2026",
          "GL-EANO-GLIOMA-2021"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic diagnostic pathway.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "INT-003",
        "display": "Dexamethasone only for edema causing symptoms, at the lowest effective dose (4 mg twice a day), with famotidine and glucose checks, and tapered off as soon as possible after surgery",
        "status": "completed",
        "guideline_ids": [
          "GL-EANO-GLIOMA-2021",
          "GL-NCCN-CNS-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic steroid plan decided when the MRI showed edema causing symptoms.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        },
        "recorded_date": "2026-07-02"
      },
      {
        "id": "INT-004",
        "display": "CT of the chest, abdomen and pelvis to exclude another primary; functional MRI with tractography; awake craniotomy with language and motor mapping for maximal safe resection; MRI within 48 hours; integrated WHO CNS5 diagnosis with IDH1 R132H immunostaining and IDH1 and IDH2 sequencing, ATRX, TERT promoter, EGFR, chromosome 7 and 10, CDKN2A, histone H3, BRAF and MGMT promoter methylation",
        "status": "completed",
        "guideline_ids": [
          "GL-NCCN-CNS-2026",
          "GL-EANO-GLIOMA-2021",
          "GL-WHO-CNS5-2021"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic surgical and pathology plan decided at the consultation.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        },
        "recorded_date": "2026-07-02"
      },
      {
        "id": "INT-005",
        "display": "No antiseizure prophylaxis, because she has had no seizure; seizure first aid taught to her and her household; levetiracetam if a seizure occurs",
        "status": "completed",
        "guideline_ids": [
          "GL-SNO-EANO-AED-2021",
          "GL-EANO-GLIOMA-2021"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seizure plan decided at the consultation.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        },
        "recorded_date": "2026-07-02"
      },
      {
        "id": "INT-006",
        "display": "Venous thromboembolism: mechanical and then low-molecular-weight heparin prophylaxis in hospital after surgery; no routine prophylaxis at home; she is taught the signs of leg clot and pulmonary embolism and to report them the same day",
        "status": "completed",
        "guideline_ids": [
          "GL-ASCO-VTE-2023",
          "GL-NCCN-CNS-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic thrombosis plan decided at the consultation.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        },
        "recorded_date": "2026-07-02"
      },
      {
        "id": "INT-007",
        "display": "Radiotherapy 60 Gy in 30 fractions with temozolomide 75 mg/m2 daily, then six cycles of temozolomide 150 to 200 mg/m2 on days 1 to 5 of each 28-day cycle; Pneumocystis prophylaxis during concurrent treatment and while lymphopenia lasts; antiemetic before each dose; blood count weekly during chemoradiation and on day 22 of each adjuvant cycle; liver tests at baseline, mid-cycle 1 and before each cycle; MRI four weeks after radiotherapy and then every two to three months, read by RANO 2.0; clinical trial screening",
        "status": "completed",
        "guideline_ids": [
          "GL-NCCN-CNS-2026",
          "GL-EANO-GLIOMA-2021",
          "GL-STUPP-2005",
          "GL-HEGI-2005",
          "GL-TMZ-LABEL",
          "GL-ASCO-SNO-2022",
          "GL-RANO-2023"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009",
            "CLM-0010"
          ],
          "synthetic_reason": "Synthetic treatment chosen by the final integrated diagnosis.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        },
        "recorded_date": "2026-07-29"
      },
      {
        "id": "INT-008",
        "display": "Tumor-treating fields with adjuvant temozolomide, worn at least 18 hours a day, with scalp checks and skin care",
        "status": "completed",
        "guideline_ids": [
          "GL-EF14-2017",
          "GL-NCCN-CNS-2026",
          "GL-EANO-GLIOMA-2021"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic device treatment chosen with her at the end of chemoradiation.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        },
        "recorded_date": "2026-09-14"
      },
      {
        "id": "INT-009",
        "display": "Falls and mobility from the first visit: home safety review, fall plan, physical therapy assessment once the treatment plan is set, and a check at every visit of strength in both legs, since new right-sided weakness adds to a left leg weakened by polio in childhood; watch for new weakness, fatigue or pain that could signal post-polio syndrome",
        "status": "completed",
        "guideline_ids": [
          "GL-EFNS-PPS-2006",
          "GL-EANO-GLIOMA-2021"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003",
            "CLM-0004",
            "CLM-0005",
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic mobility plan.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      },
      {
        "id": "INT-010",
        "display": "Early palliative care alongside cancer treatment: symptoms, coping, goals and advance care planning, and support for the people she chooses",
        "status": "completed",
        "guideline_ids": [
          "GL-ASCO-PALL-2024",
          "GL-NCCN-CNS-2026",
          "GL-EANO-GLIOMA-2021"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic palliative care referral at the end of chemoradiation.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        },
        "recorded_date": "2026-09-14"
      },
      {
        "id": "INT-011",
        "display": "Distress and depression screening at each visit, plain explanations with written information, and help to keep working as long as she wishes; she decides who receives information",
        "status": "completed",
        "guideline_ids": [
          "GL-USPSTF-DEP-2023",
          "GL-CMID-2026",
          "GL-NCCN-CNS-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic psychosocial plan.",
          "author": "The Human Record generator",
          "created": "2026-11-04T21:00:00-05:00"
        }
      }
    ],
    "guidelines": [
      {
        "guideline_id": "GL-NCCN-CNS-2026",
        "title": "NCCN Clinical Practice Guidelines in Oncology: Central Nervous System Cancers",
        "publisher": "National Comprehensive Cancer Network",
        "url": "https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1425",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-EANO-GLIOMA-2021",
        "title": "Weller M, et al. EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood. Nat Rev Clin Oncol 2021;18(3):170-186 (PMID 33293629)",
        "publisher": "European Association of Neuro-Oncology",
        "url": "https://pubmed.ncbi.nlm.nih.gov/33293629/",
        "version_or_year": "2021"
      },
      {
        "guideline_id": "GL-WHO-CNS5-2021",
        "title": "Louis DN, et al. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol 2021;23(8):1231-1251 (PMID 34185076)",
        "publisher": "Neuro-Oncology (WHO Classification of Tumours)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/34185076/",
        "version_or_year": "2021"
      },
      {
        "guideline_id": "GL-ASCO-SNO-2022",
        "title": "Mohile NA, et al. Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Guideline. J Clin Oncol 2022;40(4):403-426 (PMID 34898238)",
        "publisher": "American Society of Clinical Oncology and Society for Neuro-Oncology",
        "url": "https://pubmed.ncbi.nlm.nih.gov/34898238/",
        "version_or_year": "2022"
      },
      {
        "guideline_id": "GL-STUPP-2005",
        "title": "Stupp R, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005;352(10):987-996 (PMID 15758009)",
        "publisher": "New England Journal of Medicine",
        "url": "https://pubmed.ncbi.nlm.nih.gov/15758009/",
        "version_or_year": "2005"
      },
      {
        "guideline_id": "GL-HEGI-2005",
        "title": "Hegi ME, et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 2005;352(10):997-1003 (PMID 15758010)",
        "publisher": "New England Journal of Medicine",
        "url": "https://pubmed.ncbi.nlm.nih.gov/15758010/",
        "version_or_year": "2005"
      },
      {
        "guideline_id": "GL-EF14-2017",
        "title": "Stupp R, et al. Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma (EF-14). JAMA 2017;318(23):2306-2316 (PMID 29260225)",
        "publisher": "JAMA",
        "url": "https://pubmed.ncbi.nlm.nih.gov/29260225/",
        "version_or_year": "2017"
      },
      {
        "guideline_id": "GL-RANO-2023",
        "title": "Wen PY, et al. RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in Adults. J Clin Oncol 2023 (PMID 37774317)",
        "publisher": "Response Assessment in Neuro-Oncology working group (Journal of Clinical Oncology)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/37774317/",
        "version_or_year": "2023"
      },
      {
        "guideline_id": "GL-TMZ-LABEL",
        "title": "TEMODAR (temozolomide) capsules, prescribing information",
        "publisher": "U.S. National Library of Medicine, DailyMed (Merck Sharp & Dohme label)",
        "url": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=046a9011-3911-4d3f-a15f-fbb56d5aad56",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-SNO-EANO-AED-2021",
        "title": "Walbert T, et al. SNO and EANO practice guideline update: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Neuro Oncol 2021;23(11):1835-1844 (PMID 34174071)",
        "publisher": "Society for Neuro-Oncology and European Association of Neuro-Oncology",
        "url": "https://pubmed.ncbi.nlm.nih.gov/34174071/",
        "version_or_year": "2021"
      },
      {
        "guideline_id": "GL-ASCO-VTE-2023",
        "title": "Key NS, et al. Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Guideline Update. J Clin Oncol 2023;41(16):3063-3071 (PMID 37075273)",
        "publisher": "American Society of Clinical Oncology",
        "url": "https://pubmed.ncbi.nlm.nih.gov/37075273/",
        "version_or_year": "2023"
      },
      {
        "guideline_id": "GL-ASCO-PALL-2024",
        "title": "Sanders JJ, et al. Palliative Care for Patients With Cancer: ASCO Guideline Update. J Clin Oncol 2024;42(19):2336-2357 (PMID 38748941)",
        "publisher": "American Society of Clinical Oncology",
        "url": "https://pubmed.ncbi.nlm.nih.gov/38748941/",
        "version_or_year": "2024"
      },
      {
        "guideline_id": "GL-EFNS-PPS-2006",
        "title": "Farbu E, et al. EFNS guideline on diagnosis and management of post-polio syndrome. Eur J Neurol 2006;13(8):795-801 (PMID 16879288)",
        "publisher": "European Federation of Neurological Societies",
        "url": "https://pubmed.ncbi.nlm.nih.gov/16879288/",
        "version_or_year": "2006"
      },
      {
        "guideline_id": "GL-CMID-2026",
        "title": "CMID: Clinical Monitoring Intelligence Database, depression monograph",
        "publisher": "Aether Forge",
        "url": "https://patrickrutledge.github.io/topthirty/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-USPSTF-DEP-2023",
        "title": "Depression and Suicide Risk in Adults: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/screening-depression-suicide-risk-adults",
        "version_or_year": "2023"
      },
      {
        "guideline_id": "GL-PREV-2026",
        "title": "Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements",
        "publisher": "Aether Forge",
        "url": "https://patrickrutledge.github.io/preventative_services/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-USPSTF-AB",
        "title": "USPSTF A and B Recommendations",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation-topics/uspstf-a-and-b-recommendations",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-USPSTF-BRCA-2024",
        "title": "Breast Cancer: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-screening",
        "version_or_year": "2024"
      },
      {
        "guideline_id": "GL-USPSTF-CERV-2018",
        "title": "Cervical Cancer: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/cervical-cancer-screening",
        "version_or_year": "2018"
      },
      {
        "guideline_id": "GL-USPSTF-CRC-2021",
        "title": "Colorectal Cancer: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/colorectal-cancer-screening",
        "version_or_year": "2021"
      },
      {
        "guideline_id": "GL-USPSTF-OSTEO-2025",
        "title": "Osteoporosis to Prevent Fractures: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/osteoporosis-screening",
        "version_or_year": "2025"
      },
      {
        "guideline_id": "GL-CDC-IMZ-2026",
        "title": "Adult Immunization Schedule by Medical Condition and Other Indication",
        "publisher": "Centers for Disease Control and Prevention",
        "url": "https://www.cdc.gov/vaccines/hcp/imz-schedules/adult-medical-condition.html",
        "version_or_year": "2026"
      }
    ]
  },
  "review": {
    "schema_validation": {
      "status": "not_started",
      "notes": "Run scripts/build.ps1 -Conformance."
    },
    "clinical_review": {
      "status": "not_started",
      "notes": "Awaiting clinician review; check the urgency of imaging for new focal symptoms, the steroid dose and taper, the decision against seizure prophylaxis, the WHO CNS5 integrated diagnosis, the Stupp protocol doses and monitoring, the tumor-treating fields discussion, the RANO 2.0 reading of the first post-treatment MRI, and the fall plan for a polio survivor."
    },
    "provenance_review": {
      "status": "not_started",
      "notes": "Recent-death rule: only what she made public, what was reported during her life, and obituaries and reference accounts: the National Women's History Museum, the U.S. Olympic & Paralympic Museum, the Tennessee Encyclopedia, Women in World History, Olympedia and the Deseret News obituary. The type and treatment of her brain cancer were never made public; everything clinical is synthetic."
    },
    "safe_messaging_review": {
      "status": "not_started",
      "notes": "No mental health or substance claim is made; mood screens are synthetic and below the threshold for a safety assessment. Her death is recorded once, without detail. No relative is named in the modern episode, and no health fact or decision is attributed to any real person."
    }
  }
}
